WO2024083721A1 - A method of providing high spf to a topical surface of a body - Google Patents
A method of providing high spf to a topical surface of a body Download PDFInfo
- Publication number
- WO2024083721A1 WO2024083721A1 PCT/EP2023/078633 EP2023078633W WO2024083721A1 WO 2024083721 A1 WO2024083721 A1 WO 2024083721A1 EP 2023078633 W EP2023078633 W EP 2023078633W WO 2024083721 A1 WO2024083721 A1 WO 2024083721A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- sunscreen
- water
- leave
- surfactant
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 46
- 230000000699 topical effect Effects 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 203
- 239000000516 sunscreening agent Substances 0.000 claims abstract description 96
- 230000000475 sunscreen effect Effects 0.000 claims abstract description 95
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000006260 foam Substances 0.000 claims abstract description 28
- 238000005406 washing Methods 0.000 claims abstract description 19
- -1 olefin sulphonate Chemical class 0.000 claims description 24
- 239000004094 surface-active agent Substances 0.000 claims description 20
- 239000002736 nonionic surfactant Substances 0.000 claims description 19
- 239000007921 spray Substances 0.000 claims description 14
- 229960000655 ensulizole Drugs 0.000 claims description 12
- 239000003945 anionic surfactant Substances 0.000 claims description 10
- 239000002888 zwitterionic surfactant Substances 0.000 claims description 7
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 6
- 125000000129 anionic group Chemical group 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 6
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 claims description 6
- HEAHZSUCFKFERC-UHFFFAOYSA-N ecamsule Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC(C=C1)=CC=C1C=C1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C HEAHZSUCFKFERC-UHFFFAOYSA-N 0.000 claims description 6
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims description 5
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical group [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 5
- 239000000499 gel Substances 0.000 claims description 5
- 229960001679 octinoxate Drugs 0.000 claims description 5
- 229920000136 polysorbate Polymers 0.000 claims description 5
- KKJKXQYVUVWWJP-JLHYYAGUSA-N 4-[(e)-(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C\C1=CC=C(S(O)(=O)=O)C=C1 KKJKXQYVUVWWJP-JLHYYAGUSA-N 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 3
- 229960005193 avobenzone Drugs 0.000 claims description 3
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 claims description 3
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 claims description 3
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 claims description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 claims description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 claims description 2
- 229940071160 cocoate Drugs 0.000 claims description 2
- 229940068171 ethyl hexyl salicylate Drugs 0.000 claims description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 2
- AGGIJOLULBJGTQ-UHFFFAOYSA-N sulfoacetic acid Chemical compound OC(=O)CS(O)(=O)=O AGGIJOLULBJGTQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000011787 zinc oxide Substances 0.000 claims description 2
- ANJLMAHUPYCFQY-UHFFFAOYSA-N 4-phenyl-1h-benzimidazole-2-sulfonic acid Chemical compound C=12NC(S(=O)(=O)O)=NC2=CC=CC=1C1=CC=CC=C1 ANJLMAHUPYCFQY-UHFFFAOYSA-N 0.000 claims 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims 1
- 229960003237 betaine Drugs 0.000 claims 1
- 229930182478 glucoside Natural products 0.000 claims 1
- 150000008131 glucosides Chemical class 0.000 claims 1
- 229960000601 octocrylene Drugs 0.000 claims 1
- 229950008882 polysorbate Drugs 0.000 claims 1
- 239000004408 titanium dioxide Substances 0.000 claims 1
- 230000008901 benefit Effects 0.000 abstract description 10
- 230000002195 synergetic effect Effects 0.000 abstract description 5
- 230000004224 protection Effects 0.000 abstract description 4
- 230000037072 sun protection Effects 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 description 20
- 239000000758 substrate Substances 0.000 description 19
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 13
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 11
- 239000000344 soap Substances 0.000 description 11
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 230000005855 radiation Effects 0.000 description 9
- 238000002834 transmittance Methods 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 229920005862 polyol Polymers 0.000 description 8
- 150000003077 polyols Chemical class 0.000 description 8
- 239000003981 vehicle Substances 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 238000005507 spraying Methods 0.000 description 7
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 229920006037 cross link polymer Polymers 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- HEAHZSUCFKFERC-LRVMPXQBSA-N [(2e)-2-[[4-[(z)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C/C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C HEAHZSUCFKFERC-LRVMPXQBSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000008021 deposition Effects 0.000 description 5
- 229960003747 ecamsule Drugs 0.000 description 5
- 238000005187 foaming Methods 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000006386 neutralization reaction Methods 0.000 description 5
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 5
- 210000004761 scalp Anatomy 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical class OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- 230000003472 neutralizing effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 4
- 229960000368 sulisobenzone Drugs 0.000 description 4
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 3
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 3
- JYCQQPHGFMYQCF-UHFFFAOYSA-N 4-tert-Octylphenol monoethoxylate Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCO)C=C1 JYCQQPHGFMYQCF-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- GHMLBKRAJCXXBS-UHFFFAOYSA-N Resorcinol Natural products OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 3
- 229920002494 Zein Polymers 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 125000005907 alkyl ester group Chemical group 0.000 description 3
- 150000002191 fatty alcohols Chemical class 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229960003966 nicotinamide Drugs 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 239000011570 nicotinamide Substances 0.000 description 3
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 3
- 229920002113 octoxynol Polymers 0.000 description 3
- 230000003711 photoprotective effect Effects 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 229940093612 zein Drugs 0.000 description 3
- 239000005019 zein Substances 0.000 description 3
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 2
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 2
- VGMJYYDKPUPTID-UHFFFAOYSA-N 4-ethylbenzene-1,3-diol Chemical compound CCC1=CC=C(O)C=C1O VGMJYYDKPUPTID-UHFFFAOYSA-N 0.000 description 2
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 2
- LNFVQIGQENWZQN-UHFFFAOYSA-N 4-propan-2-ylbenzene-1,3-diol Chemical compound CC(C)C1=CC=C(O)C=C1O LNFVQIGQENWZQN-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 230000037338 UVA radiation Effects 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229940072107 ascorbate Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 2
- 229940110830 beheneth-25 methacrylate Drugs 0.000 description 2
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 2
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 2
- 210000001217 buttock Anatomy 0.000 description 2
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 229960001484 edetic acid Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 229910021485 fumed silica Inorganic materials 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical class OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 210000004247 hand Anatomy 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- XMTUJCWABCYSIV-UHFFFAOYSA-N octane-2,3-diol Chemical compound CCCCCC(O)C(C)O XMTUJCWABCYSIV-UHFFFAOYSA-N 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- IBBMAWULFFBRKK-UHFFFAOYSA-N picolinamide Chemical compound NC(=O)C1=CC=CC=N1 IBBMAWULFFBRKK-UHFFFAOYSA-N 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical class CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229940073743 steareth-20 methacrylate Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- DEDYLFIXLIFBAN-UHFFFAOYSA-N (2-hydroxy-3-propylphenyl)-phenylmethanone Chemical compound CCCC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEDYLFIXLIFBAN-UHFFFAOYSA-N 0.000 description 1
- BIIBYWQGRFWQKM-JVVROLKMSA-N (2S)-N-[4-(cyclopropylamino)-3,4-dioxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]-2-[[(E)-3-(2,4-dichlorophenyl)prop-2-enoyl]amino]-4,4-dimethylpentanamide Chemical compound CC(C)(C)C[C@@H](C(NC(C[C@H](CCN1)C1=O)C(C(NC1CC1)=O)=O)=O)NC(/C=C/C(C=CC(Cl)=C1)=C1Cl)=O BIIBYWQGRFWQKM-JVVROLKMSA-N 0.000 description 1
- PDHSAQOQVUXZGQ-JKSUJKDBSA-N (2r,3s)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2h-chromene-5,7-diol Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2OC)=CC=C(O)C(O)=C1 PDHSAQOQVUXZGQ-JKSUJKDBSA-N 0.000 description 1
- QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
- AALXZHPCKJILAZ-UHFFFAOYSA-N (4-propan-2-ylphenyl)methyl 2-hydroxybenzoate Chemical compound C1=CC(C(C)C)=CC=C1COC(=O)C1=CC=CC=C1O AALXZHPCKJILAZ-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- BIDDLDNGQCUOJQ-KAMYIIQDSA-N (z)-2,3-diphenylprop-2-enoic acid Chemical compound C=1C=CC=CC=1/C(C(=O)O)=C/C1=CC=CC=C1 BIDDLDNGQCUOJQ-KAMYIIQDSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- VEAFKIYNHVBNIP-UHFFFAOYSA-N 1,3-Diphenylpropane Chemical class C=1C=CC=CC=1CCCC1=CC=CC=C1 VEAFKIYNHVBNIP-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Chemical class OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- HDIFHQMREAYYJW-FMIVXFBMSA-N 2,3-dihydroxypropyl (e)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C\CCCCCCCC(=O)OCC(O)CO HDIFHQMREAYYJW-FMIVXFBMSA-N 0.000 description 1
- GJUXFTUISAQMQE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate;2,3-dimethoxy-3-phenylprop-2-enoic acid Chemical compound CCCCC(CC)C(=O)OCC(O)CO.COC(C(O)=O)=C(OC)C1=CC=CC=C1 GJUXFTUISAQMQE-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- ZCJJIQHVZCFSGZ-UHFFFAOYSA-N 2,8-bis(diphenylphosphoryl)dibenzothiophene Chemical compound C=1C=CC=CC=1P(C=1C=C2C3=CC(=CC=C3SC2=CC=1)P(=O)(C=1C=CC=CC=1)C=1C=CC=CC=1)(=O)C1=CC=CC=C1 ZCJJIQHVZCFSGZ-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- DWKNOLCXIFYNFV-HSZRJFAPSA-N 2-[[(2r)-1-[1-[(4-chloro-3-methylphenyl)methyl]piperidin-4-yl]-5-oxopyrrolidine-2-carbonyl]amino]-n,n,6-trimethylpyridine-4-carboxamide Chemical compound CN(C)C(=O)C1=CC(C)=NC(NC(=O)[C@@H]2N(C(=O)CC2)C2CCN(CC=3C=C(C)C(Cl)=CC=3)CC2)=C1 DWKNOLCXIFYNFV-HSZRJFAPSA-N 0.000 description 1
- LSHGMOIQPURPAK-UHFFFAOYSA-N 2-benzylidene-1,4,7,7-tetramethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C(C2=O)(C)CCC1(C)C2=CC1=CC=CC=C1 LSHGMOIQPURPAK-UHFFFAOYSA-N 0.000 description 1
- KIOWXTOCDZJCBM-UHFFFAOYSA-N 2-docosoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KIOWXTOCDZJCBM-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- ORWUQAQITKSSRZ-UHFFFAOYSA-N 2-hydroxyethyl 4-[bis[2-(2-hydroxyethoxy)ethyl]amino]benzoate Chemical compound OCCOCCN(CCOCCO)C1=CC=C(C(=O)OCCO)C=C1 ORWUQAQITKSSRZ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- OJIBJRXMHVZPLV-UHFFFAOYSA-N 2-methylpropyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(C)C OJIBJRXMHVZPLV-UHFFFAOYSA-N 0.000 description 1
- KOZZOZYINRDZOU-UHFFFAOYSA-N 2-octadecoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KOZZOZYINRDZOU-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- HMKKFLSUPRUBOO-IUPFWZBJSA-N 3,4-dihydroxy-5-[3,4,5-tris[[(z)-octadec-9-enoyl]oxy]benzoyl]oxybenzoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC1=C(OC(=O)CCCCCCC\C=C/CCCCCCCC)C(OC(=O)CCCCCCC\C=C/CCCCCCCC)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(O)=O)O)=C1 HMKKFLSUPRUBOO-IUPFWZBJSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- GNRKGNLBYVFKKD-UHFFFAOYSA-N 4-(1,3-dithian-2-yl)phenol Chemical compound C1=CC(O)=CC=C1C1SCCCS1 GNRKGNLBYVFKKD-UHFFFAOYSA-N 0.000 description 1
- ANTLBIMVNRRJNP-UHFFFAOYSA-N 4-(2-phenylethyl)benzene-1,3-diol Chemical compound OC1=CC(O)=CC=C1CCC1=CC=CC=C1 ANTLBIMVNRRJNP-UHFFFAOYSA-N 0.000 description 1
- GFBCWCDNXDKFRH-UHFFFAOYSA-N 4-(oxan-2-yloxy)phenol Chemical compound C1=CC(O)=CC=C1OC1OCCCC1 GFBCWCDNXDKFRH-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- HFGHRUCCKVYFKL-UHFFFAOYSA-N 4-ethoxy-2-piperazin-1-yl-7-pyridin-4-yl-5h-pyrimido[5,4-b]indole Chemical compound C1=C2NC=3C(OCC)=NC(N4CCNCC4)=NC=3C2=CC=C1C1=CC=NC=C1 HFGHRUCCKVYFKL-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- KTKGSSUXUIUZDA-UHFFFAOYSA-N 4-hydroxy-5-methyloxolan-3-one Chemical compound CC1OCC(=O)C1O KTKGSSUXUIUZDA-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 150000005422 4-hydroxybenzoic acid derivatives Chemical class 0.000 description 1
- PJHYOCWMKYASAB-UHFFFAOYSA-N 4-pentylbenzene-1,3-diol Chemical compound CCCCCC1=CC=C(O)C=C1O PJHYOCWMKYASAB-UHFFFAOYSA-N 0.000 description 1
- FZLSDZZNPXXBBB-KDURUIRLSA-N 5-chloro-N-[3-cyclopropyl-5-[[(3R,5S)-3,5-dimethylpiperazin-1-yl]methyl]phenyl]-4-(6-methyl-1H-indol-3-yl)pyrimidin-2-amine Chemical compound C[C@H]1CN(Cc2cc(Nc3ncc(Cl)c(n3)-c3c[nH]c4cc(C)ccc34)cc(c2)C2CC2)C[C@@H](C)N1 FZLSDZZNPXXBBB-KDURUIRLSA-N 0.000 description 1
- AMEMLELAMQEAIA-UHFFFAOYSA-N 6-(tert-butyl)thieno[3,2-d]pyrimidin-4(3H)-one Chemical compound N1C=NC(=O)C2=C1C=C(C(C)(C)C)S2 AMEMLELAMQEAIA-UHFFFAOYSA-N 0.000 description 1
- 239000004251 Ammonium lactate Substances 0.000 description 1
- 235000003911 Arachis Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- BIQUJLSTLXZGTO-UHFFFAOYSA-N C(CC)(=O)O.C(C)C=1C(=C(C(=C2N(C(C(N2)=O)=O)CCCCCC)OC)C=CC1)OC Chemical compound C(CC)(=O)O.C(C)C=1C(=C(C(=C2N(C(C(N2)=O)=O)CCCCCC)OC)C=CC1)OC BIQUJLSTLXZGTO-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Chemical class OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Chemical class 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 108010030545 N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide Proteins 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- WCBFNRQIEXLLAX-UHFFFAOYSA-N OP(=O)(O)OP(=O)O.C=C Chemical compound OP(=O)(O)OP(=O)O.C=C WCBFNRQIEXLLAX-UHFFFAOYSA-N 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 229910006069 SO3H Inorganic materials 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Chemical class OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Chemical class 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- RVERWWRSWQIGFJ-OUKQBFOZSA-N [3-methyl-4-[methyl-bis(trimethylsilyloxy)silyl]butyl] (e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate Chemical compound COC1=CC(\C=C\C(=O)OCCC(C)C[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C)=CC(OC)=C1OC RVERWWRSWQIGFJ-OUKQBFOZSA-N 0.000 description 1
- OLMIXROZPWAJNJ-UHFFFAOYSA-N [4-(1,3-dithian-2-yl)phenyl] acetate Chemical compound C1=CC(OC(=O)C)=CC=C1C1SCCCS1 OLMIXROZPWAJNJ-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 229940048299 acetylated lanolin alcohols Drugs 0.000 description 1
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 1
- 229960002916 adapalene Drugs 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical class OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940059265 ammonium lactate Drugs 0.000 description 1
- 235000019286 ammonium lactate Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940053195 antiepileptics hydantoin derivative Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- RZOBLYBZQXQGFY-HSHFZTNMSA-N azanium;(2r)-2-hydroxypropanoate Chemical compound [NH4+].C[C@@H](O)C([O-])=O RZOBLYBZQXQGFY-HSHFZTNMSA-N 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- 229960004101 bemotrizinol Drugs 0.000 description 1
- 229940111759 benzophenone-2 Drugs 0.000 description 1
- 229940079894 benzophenone-9 Drugs 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- YEAYGXLRPMKZBP-KQGICBIGSA-N bis(2-hydroxyethyl)azanium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound OCCNCCO.COC1=CC=C(\C=C\C(O)=O)C=C1 YEAYGXLRPMKZBP-KQGICBIGSA-N 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 229960001063 cinoxate Drugs 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical class O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940043237 diethanolamine Drugs 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
- GLSRFBDXBWZNLH-UHFFFAOYSA-L disodium;2-chloroacetate;2-(4,5-dihydroimidazol-1-yl)ethanol;hydroxide Chemical compound [OH-].[Na+].[Na+].[O-]C(=O)CCl.OCCN1CCN=C1 GLSRFBDXBWZNLH-UHFFFAOYSA-L 0.000 description 1
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229960000979 drometrizole Drugs 0.000 description 1
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- CBZHHQOZZQEZNJ-UHFFFAOYSA-N ethyl 4-[bis(2-hydroxypropyl)amino]benzoate Chemical compound CCOC(=O)C1=CC=C(N(CC(C)O)CC(C)O)C=C1 CBZHHQOZZQEZNJ-UHFFFAOYSA-N 0.000 description 1
- 229940035423 ethyl ether Drugs 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229910000286 fullers earth Inorganic materials 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- NITYDPDXAAFEIT-DYVFJYSZSA-N ilomastat Chemical compound C1=CC=C2C(C[C@@H](C(=O)NC)NC(=O)[C@H](CC(C)C)CC(=O)NO)=CNC2=C1 NITYDPDXAAFEIT-DYVFJYSZSA-N 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- VFQXVTODMYMSMJ-UHFFFAOYSA-N isonicotinamide Chemical compound NC(=O)C1=CC=NC=C1 VFQXVTODMYMSMJ-UHFFFAOYSA-N 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940033357 isopropyl laurate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940062711 laureth-9 Drugs 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- PVWXTVUZGJXFJQ-CCEZHUSRSA-N methyl (E)-4-methyl-3-phenyl-2-propan-2-ylpent-2-enoate Chemical compound COC(=O)C(\C(C)C)=C(/C(C)C)C1=CC=CC=C1 PVWXTVUZGJXFJQ-CCEZHUSRSA-N 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- AYOOGWWGECJQPI-NSHDSACASA-N n-[(1s)-1-(5-fluoropyrimidin-2-yl)ethyl]-3-(3-propan-2-yloxy-1h-pyrazol-5-yl)imidazo[4,5-b]pyridin-5-amine Chemical compound N1C(OC(C)C)=CC(N2C3=NC(N[C@@H](C)C=4N=CC(F)=CN=4)=CC=C3N=C2)=N1 AYOOGWWGECJQPI-NSHDSACASA-N 0.000 description 1
- VOVZXURTCKPRDQ-CQSZACIVSA-N n-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3r)-3-hydroxypyrrolidin-1-yl]-5-(1h-pyrazol-5-yl)pyridine-3-carboxamide Chemical compound C1[C@H](O)CCN1C1=NC=C(C(=O)NC=2C=CC(OC(F)(F)Cl)=CC=2)C=C1C1=CC=NN1 VOVZXURTCKPRDQ-CQSZACIVSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- LJZULWUXNKDPCG-UHFFFAOYSA-N nonane-1,2-diol Chemical compound CCCCCCCC(O)CO LJZULWUXNKDPCG-UHFFFAOYSA-N 0.000 description 1
- DLVYTANECMRFGX-UHFFFAOYSA-N norfuraneol Natural products CC1=C(O)C(=O)CO1 DLVYTANECMRFGX-UHFFFAOYSA-N 0.000 description 1
- OXGBCSQEKCRCHN-UHFFFAOYSA-N octadecan-2-ol Chemical compound CCCCCCCCCCCCCCCCC(C)O OXGBCSQEKCRCHN-UHFFFAOYSA-N 0.000 description 1
- UJWVPVVMYOBBIY-UHFFFAOYSA-N octane-3,4-diol Chemical compound CCCCC(O)C(O)CC UJWVPVVMYOBBIY-UHFFFAOYSA-N 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- LXTZRIBXKVRLOA-UHFFFAOYSA-N padimate a Chemical compound CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 LXTZRIBXKVRLOA-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- ONJQDTZCDSESIW-UHFFFAOYSA-N polidocanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ONJQDTZCDSESIW-UHFFFAOYSA-N 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 229940100498 polysilicone-15 Drugs 0.000 description 1
- 229920002282 polysilicones-15 Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229940099404 potassium cocoate Drugs 0.000 description 1
- 229940079988 potassium cocoyl glycinate Drugs 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Chemical class CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940096501 sodium cocoamphoacetate Drugs 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- 239000004296 sodium metabisulphite Substances 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- GOJYXPWOUJYXJC-UHFFFAOYSA-M sodium;2-[1-(2-hydroxyethyl)-2-undecyl-4,5-dihydroimidazol-1-ium-1-yl]acetate;hydroxide Chemical compound [OH-].[Na+].CCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O GOJYXPWOUJYXJC-UHFFFAOYSA-M 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- 229950006451 sorbitan laurate Drugs 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000011493 spray foam Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical group OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Chemical class 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Chemical class 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Definitions
- the present invention relates to a method of delivering high Sun Protection Factor (SPF) to a topical surface of a body preferably the human body.
- SPF Sun Protection Factor
- the method more preferably provides for synergistic benefit of SPF over and above that which can be delivered through each of two individual steps carried out sequentially viz. washing of the skin with a specific cleansing foam composition delivered from a container with a pump followed by the step of applying a sunscreen composition on to the same skin surface.
- Solar radiation includes about 5% ultraviolet (UV) radiation, wavelength of which is between 200 nm and 400 nm. It is further classified into three regions: from 320 to 400 nm (UV-A), 290 to 320 nm (UV-B) and from 200 to 290 nm (UV-C). Exposure to UV-A and UV-B radiation for short period is known to cause reddening of the skin and localized irritation. Continued and prolonged exposure can lead to sunburn, melanoma and formation of wrinkles. It is also reported that UV radiation causes significant damage to hair. Therefore, people desire to protect their skin and hair from the harmful effects of both UV-A and UV-B radiation.
- compositions that one can apply on to the skin such as creams, lotions or gels have been reported for preventing and/or protecting the skin from harmful effects of ultraviolet radiation.
- These cosmetic compositions usually comprise different types of organic sunscreen agents, especially ones capable of absorbing the UV-A and/or UV-B radiation present in the sun’s rays.
- both UV-A and UV-B sunscreens are usually incorporated in photo-protective compositions so as to provide protection over the entire range of UV radiation.
- Such leave-on compositions are applied on to skin before a person goes outdoors and they remain thereon till the person has a next wash.
- the present inventors with their years of experience in understanding the nature of available sunscreens; the knowledge of interfacial science of surfactant systems and through extensive experimentation set out find a solution to the problem of delivering high SPF on to skin. They hit upon a unique two step method that provides for synergistic improvement in SPF as compared to each of the steps individually.
- the method comprises the step of washing the skin with a foam composition comprising water soluble sunscreens which is generated from a container fitted with a foam generating pump; followed by the step of applying a leave-on sunscreen composition on to skin.
- EP1261688 (Unilever, 2001) discloses a personal wash composition which deposits high levels of sunscreen (SPF>2) while maintaining good lather (i.e. suffer minimal lather degradation over time relative to compositions with more “oily” sunscreens). Enhanced deposition is found from both bar and liquid compositions and is based on the solubility or non-solubility of the sunscreen used.
- the present inventors have found that there is a limit to the SPF that can be achieved with either a wash-off sunscreen composition or a leave-on sunscreen composition, the latter being more efficacious. Incorporation of higher amount of sunscreens as taught in the prior art does not, in general, provide for continuous increase+ in the deposition efficacy and thereby the SPF achieved.
- a method of providing high SPF to a topical surface of a body comprising the steps of (a) washing the surface with a wash-off composition generated as a foam from a container comprising a pump, said wash-off composition comprising
- a cosmetically acceptable carrier preferably diluted with water followed by
- the second aspect of the present invention relates to a kit comprising
- a hand held container comprising a pump capable of generating a foam, said container comprising a wash-off composition comprising 0.1 to 10 wt% of a water-soluble UVA sunscreen; 0.1 to 10 wt% of a water-soluble UVB sunscreen; 3 to 80 wt%, preferably 6 to 80 wt% a mild surfactant selected from one or more of an anionic, zwitterionic or non-ionic surfactant; and a cosmetically acceptable carrier;
- a wash-off composition as used herein, is meant to include a composition for cleaning topical surfaces of mammals, especially humans. This composition is particularly useful for use on the sun-exposed parts of the body. Such a composition is generally of the rinse off type which means that the composition is high in surfactants which are known to help in cleaning surfaces to make them free of oils and dirt.
- the wash-off composition is generally used by diluting with water as it is applied on to skin, scalp or hair, after which the consumer works up a lather to ensure that the dirt and oil on the surface are solubilized in the micelles of the surfactant solution and the body is then rinsed with copious amounts of water to ensure that the surface is substantially free of the composition.
- the wash-off composition of the present invention is included in a container that is fitted with a pump. When the pump on the container is actuated, the composition issues as a foam from the container which is then used by the consumer for washing the desired surface of the body.
- skin as used herein is meant to include skin on the face and body (e.g., neck, chest, back, arms, underarms, hands, legs, buttocks and scalp) and especially to the sun exposed parts thereof.
- the wash-off composition of the invention is also of relevance to application on any other keratinous substrates of the human body other than skin e.g. scalp and hair where products may be formulated with specific aim of providing photo-protection.
- the dirt and oil on the skin surface are substantially removed during the washing and rinsing process.
- the specific combination of the sunscreens incorporated ensures that they deposit in much higher amounts than is generally expected from rinse off products, in such a way that the deposited sunscreens interact synergistically with the sunscreens applied thereafter from the leave-on composition to provide the enhanced SPF and LIVAPF benefit.
- the enhanced deposition leads to delivering high Sun Protection Factor (SPF).
- high SPF as per this invention is meant a composition that preferably has an SPF at least 10, more preferably at least 15, more preferably higher than 20, further more preferably higher than 30, yet more preferably higher than 50, in many cases higher than 80, and in optimum cases higher than 100. Most preferably the invention provides for SPF in the range of 20 to 50. The SPF could be as high as 160. The SPF in the present invention is measured using transmittance measurement technique. The method of the invention also delivers high LIVAPF. By high LIVAPF is meant that the method delivers II VAPF(initiai) of at least 4, preferably higher than 8, further preferably higher than 12, further more preferably higher than 16, and most preferably higher than 20. In especially preferred aspects, the present invention delivers LIVAPF value in the range of 4 to 16. The LIVAPF could be as high as 40.
- the wash-off composition which is used in the first step of the method of the invention comprises 0.1 to 10 wt% of a water-soluble UVA sunscreen; 0.1 to 10 wt% of a water-soluble UVB sunscreen; 3 to 80 wt%, preferably 6 to 80 wt% a mild surfactant selected from one or more of an anionic, zwitterionic and non-ionic surfactant; and a cosmetically acceptable carrier.
- water soluble sunscreen whether of the UVA type, or of the UVB type, is meant that the solubility in water of the sunscreen is higher than 10 g/l preferably higher than 50 g/l at 25 °C.
- the wash-off composition is included in a container.
- the container is preferably capable of being hand-held.
- the container comprises a pump at its head such that on actuation of the pump by pressing down with a finger or a thumb the composition mixes with air and issues from the container as a foam.
- the container comprises a sprayable foamable composition. It may be delivered using a spray device that contains the foamable composition.
- the spray device may comprise a bottle having a nozzle and a spray pump dispenser.
- the invention thus provides a cleaning system comprising a spraying device.
- the spraying device comprises a container holding the foamable wash-off composition, a spray head, and a liquid supply arrangement for transferring the foamable wash- off composition from the container to the spray head to form the foam.
- the foam generated generally has a density of less than 0.4 g/ml when ejected from the spray device through the spray head.
- the spraying device used in the present invention preferably comprises a container having an internal volume of 25 to 1000 ml, more preferably of 50 to 800 ml, even more preferably 60 to 750 ml and most preferably of 75 to 500 ml.
- the spraying device preferably comprises a positive displacement pump that acts directly on the foamable wash-off composition. The pump draws the composition up into the liquid supply arrangement and transfers the composition to the spray head, from which it is discharged in the form of a foam, preferably through a nozzle.
- the dispensing of the wash-off composition is preferably powered by a user's efforts, i.e, the liquid cleaning composition is not dispensed under pressure by simply actuating a valve and requires manual triggering.
- the spraying device employed in accordance with the present invention is preferably selected from a trigger spray foam bottle, a squeeze foam bottle and a foam pump. Most preferably the spraying device is a squeeze foam bottle or a foam pump. In another preferred embodiment, the spray device is configured to mix the liquid cleaning composition with air before it is dispensed from the spray head.
- the composition can be placed into the reservoir of a plastic squeeze bottle which contains a foaming spray head or other foam producing means.
- Squeezing the container causes the wash-off composition to leave the reservoir and enter an air-mixing or foaming chamber via an internal dip tube.
- the foam produced in the foaming chamber is often passed through a homogenizing element interposed between the air-mixing chamber and the discharge orifice to homogenise and control the consistency of the discharged foam. Further compression of the foam discharges the foam from a discharge cap as a uniform non-pressurised aerated foam.
- the side walls of the container may be rigid and the dip tube may be fitted with a pump that is actuated by a push button. When composition is drawn by the pump through to the air mixing or foaming chamber, the desired foam is produced.
- the preferred UVB sunscreen for use in the wash-off composition is phenyl benzimidazole sulphonic acid (PBSA) or benzylidene camphor sulfonic acid, preferably PBSA.
- PBSA phenyl benzimidazole sulphonic acid
- PBSA benzylidene camphor sulfonic acid
- PBSA has the chemical structure:
- PBSA also known as Ensulizole is commercially available as Eusolex 232 (from Merck KGaA). PBSA is also available under the brand names Neo Heliopan Hydro (from Symrise), Parsol HS (from DSM) and Sunsafe ES (from Uniproma). It is generally used in the water solubilized form after neutralization to deliver desired benefit.
- Neo Heliopan Hydro from Symrise
- Parsol HS from DSM
- Sunsafe ES from Uniproma
- It is generally used in the water solubilized form after neutralization to deliver desired benefit.
- Benzylidene camphor sulfonic acid has the chemical structure: It is generally used in the water solubilized form pre/post neutralization to deliver desired benefit.
- the preferred UVA sunscreen for use in the wash-off composition is one or more of disodium phenyl dibenzimidazole tetrasulfonate (Neoheliopan AP) or terephthalylidene dicamphor sulfonic acid (TDSA).
- disodium phenyl dibenzimidazole tetrasulfonate Neoheliopan AP
- TDSA terephthalylidene dicamphor sulfonic acid
- Di sodium phenyl dibenzimidazole tetra sulfonate also known as bisdisulizole disodium has the chemical structure as given below:
- Neo heliopan AP from Symrise Shanghai Ltd
- Sunsafe DPDT from Uniproma
- TDSA Terephthalylidene dicamphor sulfonic acid
- Ecamsule It is also known as Ecamsule. This is commercially available as Mexoryl SX (US4585597) by L’ Oreal or Sunsafe TDSA (from Uniproma). It can be used as parent acid or its salts in water solubilized form to deliver the desired benefit.
- the wash-off composition preferably comprises 0.1 to 10 wt%, more preferably 0.25 to 8 wt%, even more preferably 0.5 to 5% water soluble UVA sunscreen.
- the composition preferably comprises 0.1 to 10 wt%, more preferably 0.25 to 8 wt%, even more preferably 0.5 to 5% water soluble UVB sunscreen.
- sunscreens which have both a UVA screening efficacy as well as a UVB screening efficacy. Such sunscreens provide both UVA and UVB protection e.g. benzophenone-4.
- Benzophenone-4 (Sulisobenzone) has the chemical structure:
- Such sunscreens may also be included in the wash-off composition of the invention.
- sunscreens When included, it is to be understood that it is taken as having included one type of sunscreen i.e. either a UVA sunscreen or a UVB sunscreen and not both.
- a UVA sunscreen when included as a UVA sunscreen, it is essential to include another sunscreen as a UVB sunscreen.
- UVB sunscreen when included as a UVB sunscreen, it is essential to include another sunscreen as a UVA sunscreen.
- the water-soluble sunscreens for inclusion in the wash-off composition of the present invention are generally commercially available in the acid form. When included in the composition in the acid form (pre /partially neutralized forms) i.e.
- the wash-off composition additionally comprises a neutralising agent to convert the acid form into the salt form, in which form it is known to be active as a sunscreen with an exception to Mexoryl SX which can act as sunscreen with and without neutralization.
- the neutralising agent is preferably in 0.05% to 4% by weight of the composition.
- the neutralising agent is preferably an inorganic or an organic alkali.
- Organic alkali is preferably an amine such as triethanol amine or diethanol amine.
- the present inventors have observed that the inorganic alkali is especially preferred.
- Most preferred metal hydroxide for inclusion as neutralising agent in the composition of the invention are sodium hydroxide or potassium hydroxide.
- One of the objects of the first step of the method of the invention is to ensure that the sunscreen is deposited in as high an amount as possible on the skin through the wash-off process. Without wishing to be bound by theory, the inventors believe that this is achieved through the select combination of sunscreens chosen by their structure and solubility in the select foaming surfactant composition which determine their partition between rinse away water and cleansing surface resulting in high sunscreen deposition.
- the wash-off composition of the invention comprises a mild surfactant which is delivered in the form of a foam which aids in the cleaning action.
- the mild surfactant is included in 3 to 80% preferably 6 to 80%, further more preferably 10 to 75% by weight of the composition.
- a mild surfactant is meant that the Zein Number is less than 100 or or has a value of less than 6% zein dissolution weight %.
- the Zein dissolution wt% is defined in the reference US9655866B2 “Mild antibacterial cleansing compositions”.
- the mild surfactant is preferably an anionic surfactant which is selected from one or more of an isethionate, glycinate, cocoate, olefin sulphonate, sulphoacetate and sulphosuccinate surfactant.
- Preferred mild anionic surfactants are chosen from one or more of sodium cocoyl isethionates, potassium cocoyl glycinate and potassium cocoate, alpha olefin sulphonate (AOS), sodium lauryl sulfoacetate, alkyl ether sulfoacetates, sodium dioctylsulphosuccinate, and alkyl ether sulfosuccinates.
- the wash-off composition of the invention preferably comprises a mild amphoteric surfactant which may be chosen from one or more of cocoamidopropyl hydroxysultaine, coco amidopropyl betaine, sodium lauroamphoacetate and sodium cocoamphoacetate.
- the wash-off composition comprises from 0.1 to 10 wt.%, preferably from 0.5 to 8 wt.%, more preferably from 1 to 5 wt.% of the mild amphoteric surfactant.
- the wash-off composition of the invention preferably comprises a mild non-ionic surfactant which may be chosen from one or more of Polysorbate 20, Polysorbate 60, sorbitan laurate, decyl glucoside, and lauryl glucoside.
- a mild non-ionic surfactant which may be chosen from one or more of Polysorbate 20, Polysorbate 60, sorbitan laurate, decyl glucoside, and lauryl glucoside.
- the wash-off composition comprises more than 0.5 but less than 30%, preferably from 1 to 20 % by weight of the mild non-ionic surfactant.
- the wash-off composition of the invention comprises a cosmetically acceptable carrier.
- the cosmetically acceptable carrier is preferably an aqueous solution/ dispersion of cosmetically acceptable adjuvents.
- Water is generally included in the wash-off composition of the invention.
- the wash-off composition is generally formulated in liquid, emulsion or gel form where the water content is generally in the range of 50 to 95%, preferably in the range of 60 to 85% by weight of the composition.
- the wash-off composition preferably comprises a polyhydric alcohol (also called polyol) or mixture of polyols.
- Polyol is a term used herein to designate a compound having multiple hydroxyl groups (at least two, preferably at least three) which is highly water soluble.
- Many types of polyols are available including: relatively low molecular weight short chain polyhydroxy compounds such as glycerol and propylene glycol; sugars such as sorbitol, manitol, sucrose and glucose; modified carbohydrates such as hydrolyzed starch, dextrin and maltodextrin, and polymeric synthetic polyols such as polyalkylene glycols, for example polyoxyethylene glycol (PEG) and polyoxypropylene glycol (PPG).
- PEG polyoxyethylene glycol
- PPG polyoxypropylene glycol
- Especially preferred polyols are glycerol, sorbitol and their mixtures. Most preferred polyol is glycerol. In a preferred embodiment, the bars of the invention comprise 0 to 8%, preferably 1 to 7.5% by wt. polyol A preferred wash-off composition may additionally include up to 30 wt% benefit agents. Preferred benefit agents include moisturizers, emollients, and anti-ageing compounds.
- ingredients like anti-oxidants, perfumes, polymers, chelating agents, colourants, deodorants, dyes, enzymes, foam boosters, germicides, anti-microbials, lathering agents, pearlescers, skin conditioners, stabilizers or superfatting agents, may be added in suitable amounts in the process of the invention.
- the ingredients are added after the saponification step.
- Sodium metabisulphite, ethylene diamine tetra acetic acid (EDTA), borax or ethylene hydroxy diphosphonic acid (EH DP) are preferably added to the formulation.
- the present invention includes a second step of the method which comprises applying a leave- on composition comprising a sunscreen and a cosmetically acceptable vehicle on to the desired topical surface e.g a skin surface.
- a leave-on composition is meant a composition that is applied on the desired topical surface and left thereon till such time that the surface is cleaned usually after several hours or after one day when a person normally has his bath or shower or any other personal cleansing routine.
- the leave-on composition of the present invention can be in the form of a liquid, lotion, cream, spray, stick or gel.
- “Skin” as used herein is meant to include skin on the face and body (e.g., neck, chest, back, arms, underarms, hands, legs, buttocks and scalp) and especially to the sun exposed parts thereof.
- the leave-on composition of the invention is also of relevance to application on any other keratinous substrates of the human body other than skin e.g. scalp and hair where products may be formulated with specific aim of providing photo-protection.
- the sunscreen in the leave-on composition is an organic UVA sunscreen, an organic UVB sunscreen, an inorganic sunblock or mixtures thereof preferably a combination of an organic UVB sunscreen and an organic UVA sunscreen.
- the leave-on composition comprises a UVA organic sunscreen that absorbs UVA radiations and prevent them from reaching a surface e.g. skin of a user.
- sunscreens that may be used as UVA organic sunscreen in the composition are dibenzoylmethane compound, bisdisulizole disodium (commercially available as Neo Heliopan® AP), diethylamino hydroxybenzoyl hexyl benzoate (commercially available as Uvinul® A Plus), Ecamsule (commercially available as Mexoryl SX), Dimethoxyphenyl-[1-(3,4)]-4,4-dimethyl 1 ,3- pentanedione, and Methyl anthranilate.
- sunscreen that may be used as UVA organic sunscreen in the leave-on composition is selected from a dibenzoylmethane compound or diethylamino hydroxy benzoyl hexyl benzoate, preferably a dibenzoylmethane compound.
- the leave-on composition comprises from 0.01 to 10 wt%, more preferably from 0.1 to 8 wt%, even more preferably from 1 to 6 wt%, further more preferably 1 to 5 wt%, still more preferably from 1 to 3 wt%, yet more preferably from 1 to 2.5 wt% of one or more UVA organic sunscreens.
- the leave-on composition may comprise a UV-B organic sunscreen.
- UVB organic sunscreens absorb UVB radiations and prevent them from reaching a surface e.g. skin of a user.
- Examples of UVB organic sunscreens that may be used in the composition include compounds from the class of cinnamic acid, salicylic acid, diphenyl acrylic acid, Benzylidene camphor and derivatives thereof.
- Examples of such compounds include 2-ethylhexyl salicylate (commercially available as OctisalateTM), 3,3,5-Trimethylcyclohexyl 2-hydroxybenzoate (commercially available as HomosalateTM), Ethylhexyl Methoxycinnamate (commercially available as NeoHelipan® AV), 2-ethylhexyl 2-cyano-3,3-diphenylacrylate (OCR; commercially available as OctocryleneTM), 2- Hydroxy-4-methoxybenzophenone (commercially available as OxybenzoneTM), 2-ethyl-hexyl-4- methoxy cinnamate (MCX; commercially available as Parsol MCXTM), 3-Benzylidene camphor, Benzylidene camphor sulfonic acid, DEA methoxycinnamate, Cinoxate, Diethylhexyl butamido triazone, Digalloyl trioleate, Diisopropyl methyl cinnam
- UVB organic sunscreens may preferably be incorporated from 0.1 to 10 wt%, more preferably from 0.5 to 7 wt%, even more preferably from 1 to 5 wt%, further more preferably from 1 to 3.5 wt%, yet more preferably from 1 to 3 wt%, still more preferably 1 to 2.5 wt% in the leave-on composition.
- the leave-on composition may comprise a LIVB/A sunscreen which are sunscreens that absorb both UVB and UVA radiations and prevent them from reaching the applied surface.
- LIVB/A sunscreens examples include Benzophenone derivatives.
- Benzophenone-1 Benzophenone-2, Benzophenone-3, Benzophenone-4, Benzophenone-5, Benzophenone-6, Benzophenone-8, Benzophenone-9, Beta-2-Glucopyranoxy propyl hydroxy benzophenone, Bisethylhexyloxyphenol methoxyphenyl triazine (Tinosorb S), Drometrizole, Drometrizole trisiloxane, Methylene bis-benzotriazolyl tetramethylbutylphenol (Tinosorb M).
- the leave-on composition comprises from 0.01 to 10 wt%, more preferably from 0.1 to 8 wt%, even more preferably from 1 to 6 wt%, further more preferably 1 to 5 wt%, still more preferably from 1 to 3 wt%, yet more preferably from 1 to 2.5 wt% of one or more UVB/A organic sunscreens.
- the composition may comprise an inorganic sunblock.
- inorganic sunblock that may be used in the composition include zinc oxide (ZnO), iron oxide, silica, such as fumed silica and titanium dioxide (TiO2).
- ZnO zinc oxide
- iron oxide iron oxide
- silica such as fumed silica
- TiO2 titanium dioxide
- inorganic sunblock that may be used in the composition are selected from TiC ZnO and mixtures thereof.
- inorganic sunblock may preferably be incorporated from 0.1 to 25% wt%, more preferably from 0.5 to 20 wt%, even more preferably from 1 to 15 wt%, further more preferably from 1 to 10 wt%, yet more preferably from 1 to 5 wt%, still more preferably 1 to 3 wt%, in the composition.
- the leave-on composition may comprise one or more agents for providing glow to the skin.
- the agents include niacinamide, picolinamide, 4-alkyl substituted resorcinol, vitamin B6, vitamin C, vitamin A, glutathione precursors, galardin, adapalene, aloe extract, ammonium lactate, arbutin, azelaic acid, butyl hydroxy anisole, butyl hydroxy toluene, citrate esters, deoxyarbutin, 1 ,3-diphenyl propane derivatives, 2,5-dihydroxybenzoic acid and its derivatives, 2- (4-acetoxyphenyl)-1 ,3-dithiane, 2-(4-hydroxyphenyl)-1 ,3-dithiane, ellagic acid, gluco pyranosyl- 1 -ascorbate, gluconic acid, glycolic acid, green tea extract, 4-Hydroxy-5-methyl-3[2H]-furanone, 4-hydroxyanisole
- the agent for providing glow to the skin is selected from the group consisting of niacinamide, picolinamide, isonicotinamide, 12-hydroxystearic acid, 4-alkyl substituted resorcinol and mixtures thereof.
- the skin glow agent used in the leave-on composition is niacinamide.
- the skin glow agent selected is 4-alkyl substituted resorcinol selected from the group consisting of 4-ethyl resorcinol (4-ER), 4-isopropyl resorcinol (4-IPR), 4- butyl resorcinol (4-BR), 4-pentyl resorcinol(4-PR), 4-phenylethyl resorcinol (4-PER), 4-HR and mixtures thereof.
- the agent is selected from the group consisting of 4-ER, 4-HR and mixtures thereof. Further more preferably, the agent selected is 4-HR.
- the leave-on composition comprises from 0.001 to 10 wt%, more preferably from 0.01 to 8 wt%, even more preferably from 0.1 to 7 wt%, further more preferably from 0.1 to 5 wt%, still more preferably from 0.1 to 3 wt%, yet more preferably from 0.1 to 1 wt% and still further more preferably from 0.25 to 0.5 wt% of a skin glow agent.
- the leave-on composition comprises a cosmetically acceptable vehicle.
- the cosmetically acceptable vehicle is preferably in the form of an oil, liquid, stick, cream, lotion, spray or gel.
- the cosmetically acceptable vehicle preferably includes ingredients like surfactant e.g. non-ionic surfactant, fatty acid, soap, water, polymer, emollients, solvents, powders, preservatives, or optional ingredients. Details on the various possible ingredients for inclusion in the cosmetically acceptable vehicle are given below.
- the leave-on composition comprises a nonionic surfactant.
- the nonionic surfactant is selected from those having HLB value in the range 9 to 20, preferably 10 to 19, more preferably 12 to 18, even more preferably 13 to 17 and yet more preferably 15 to 17.
- Typical values for various surfactants are given below:
- a value from 4 to 8 indicates an anti-foaming agent
- a value from 7 to 11 indicates a W/O (water in oil) emulsifier
- a value from 12 to 16 indicates oil in water emulsifier
- a value from 11 to 14 indicates a wetting agent
- a value from 12 to 15 is typical of detergents
- a value of 16 to 20 indicates a solubiliser or a hydrotrope.
- the nonionic surfactant having HLB value in the range 9 to 20 is selected from fatty alcohol ethoxylates, alkyl phenol ethoxylates, polyoxyethylene sorbitan alkyl esters and mixtures thereof.
- the nonionic surfactants are ones with at least 9 alkylene oxide groups preferably at least 9 ethylene oxide groups.
- the nonionic surfactant having HLB value in the range 9 to 20 that may be present in the composition is fatty alcohol ethoxylate with saturated carbon chain having HLB higher than 15.5.
- the leave-on composition comprises 0.5 to 5 wt%, more preferably 1 to 4 wt%, even more preferably from 2 to 3 wt% nonionic surfactant having HLB in the range 9 to 20.
- the leave-on composition comprises fatty acid.
- Fatty acids when present in a composition along with a soap provides the so-called vanishing cream effect, i.e. a composition, when applied on to the human skin, vanishes on the skin leaving behind no significant streaks of the composition.
- the leave-on composition comprises fatty acids having 10 to 30, more preferably 12 to 25, even more preferably 14 to 20, further more preferably 16 to 18 carbon atoms.
- Examples of fatty acids that may be used in the composition include pelargonic, lauric, myristic, palmitic, stearic, isostearic, oleic, linoleic, arachidic, behenic, erucic acid and mixtures thereof.
- the fatty acid that may be used is stearic acid or palmitic acid or a mixture thereof.
- the fatty acid in the present invention is preferably hystric acid which is substantially (generally about 90 to 95%) a mixture of stearic acid and palmitic acid in a ratio of between 55:45 to 45:55.
- the leave-on composition comprises from 2.25 to 25 wt%, more preferably from 4 to 22 wt%, even more preferably from 6 to 20 wt%, further more preferably from 8 to 19 wt% and still more preferably from 10 to 18 wt% and yet more preferably from 12 to 16 wt% fatty acid.
- the leave-on composition comprises soap.
- Soap when present in combination with fatty acid in the composition, provides the vanishing cream effect.
- soap in the leave- on composition is generally prepared by in-situ neutralization of fatty acid that may be present in the composition.
- the soap has a carbon chain length that corresponds to the chain length of fatty acid in the composition.
- the soap is formed from the fatty acid through use of alkali metal hydroxides e.g. sodium hydroxide or potassium hydroxide. Of the two, potassium hydroxide is more preferred.
- the soap is preferably a potassium soap (potassium salt of fatty acid).
- the leave-on composition comprises from 0.1 to 10 wt%, more preferably from 0.25% to 8 wt%, even more preferably from 0.5 to 7 wt%, further more preferably from 0.5 to 5 wt% soap, even further more preferably 0.5% to 3%.
- the leave-on composition comprises water in amount from 5 to 99.9 wt%, more preferably from 10 to 95 wt%, even more preferably from 15 to 90 wt%, further more preferably from 20 to 80 wt%, still more preferably 25 to 75 wt% and yet more preferably 30 to 70 wt%.
- the leave-on composition comprises a polymer.
- the polymer acts as thickener in the composition and improves sensorial properties of the composition.
- the polymer is preferably selected from the following classes: acrylate I R-methacrylate copolymer e.g. acrylates/ steareth-20 methacrylate copolymer (commercially available as AculynTM 22) and acrylates/ beheneth-25 methacrylate copolymer (commercially available as AculynTM 28), acrylate I R-methacrylate crosspolymer e.g. acrylates/steareth-20 methacrylate crosspolymer (commercially available as AculynTM 88), acrylates copolymer (commercially available as AculynTM 33), acrylate/R-alkyl acrylate crosspolymer e.g.
- acrylate I R-methacrylate copolymer e.g. acrylates/ steareth-20 methacrylate copolymer (commercially available as AculynTM 22) and acrylates/ beheneth-25 methacrylate copolymer (commercially available as Aculy
- acrylates/C10-C30 alkyl acrylate crosspolymer (commercially available as PemulenTM TR-2), copolymer of ammonium acryloyldimethyltaurate with vinyl pyrrolidone (commercially available as Aristoflex® AVC), copolymer of sodium acryloyldimethyltaurate with vinyl pyrrolidone (commercially available as Aristoflex® AVS); and crosspolymer of acryloyldimethyltaurate with R-alkyl acrylate and methyacrylate e.g. Ammonium acryloyldimethyltaurate/ beheneth-25 methacrylate crosspolymer (commercially available as Aristoflex® HMB and Aristoflex® BLV).
- the leave-on composition comprises 0.1 to 5 wt%, more preferably 0.25 to 4.5 wt%, even more preferably 0.5 to 4 wt%, further more preferably from 0.75 to 3.5 wt%, still more preferably from 0.75 to 2.75 wt% polymer.
- the leave-on composition comprises emollients.
- emollients that may be used in the leave-on composition include stearyl alcohol, glyceryl monoricinoleate, mink oil, cetyl alcohol, isopropyl isostearate, isobutyl palmitate, isocetyl stearate, oleyl alcohol, isopropyl laurate, hexyl laurate, decyl oleate, octadecan-2-ol, isocetyl alcohol, eicosanyl alcohol, behenyl alcohol, cetyl palmitate, silicone oils such as dimethylpolysiloxane, din-butyl sebacate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, butyl stearate, polyethylene glycol, triethylene glycol, lanolin, cocoa butter, corn oil, cotton seed oil, olive oil, palm kernel oil, rap
- the leave-on composition comprises solvents.
- solvents that may be used in the composition include ethyl alcohol, isopropanol, acetone, ethylene glycol ono ethyl ether, diethylene glycol mono butyl ether, diethylene glycol mono ethyl ether and mixtures thereof.
- the leave-on composition comprises powders.
- powders that may be used in the composition include chalk, talc, fullers earth, kaolin, starch, gums, colloidal silica sodium polyacrylate, tetra alkyl and/or trialkyl aryl ammonium smectites, chemically modified magnesium aluminium silicate, organically modified montmorillonite clay, hydrated aluminium silicate, fumed silica, carboxyvinyl polymer, sodium carboxymethyl cellulose, ethylene glycol monostearate and mixtures thereof.
- the leave-on composition comprises preservatives to protect against the growth of potentially harmful microorganisms.
- preservatives examples include alkyl esters of para-hydroxybenzoic acid, hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds.
- ingredients that may be used as preservative in the composition are sodium benzoate, iodopropynyl butyl carbamate, methylisothiazolinone, iodopropynylbutylcarbamate, phenoxyethanol, methyl paraben, propyl paraben, imidazolidinyl urea, sodium dehydroacetate, ethylhexylglycerin, benzyl alcohol, alkane diols and mixtures thereof.
- the alkane diols that are suitable for use as preservative are C6-C12 alkanes that are vicinally substituted with hydroxy groups.
- Illustrative examples include 1 ,2-octane diol (caprylyl glycol), 2,3-octane diol, 1 ,2-nonane diol, 1 ,2-decane diol, 1 ,2-hexane diol, 3,4-octane diol, mixtures thereof or the like where caprylyl glycol is typically the most preferred.
- preservatives are added preferably in an amount 0.001 to 5 wt%, more preferably 0.01 to 3 wt% and most preferably 0.02 to 2 wt%, even most preferably 0.25 to 1.5%.
- the leave-on composition comprises a range of other optional ingredients that include antioxidants, binders, buffering agents, colorants, astringents, fragrance, opacifying agents, conditioners, exfoliating agents, pH adjusters, skin sensates, skin soothing agents, and skin healing agents.
- the present invention relates to the method as described in detail herein above viz. the step of washing the surface with the wash-off composition followed by rinsing followed by applying a leave-on composition. It is preferrable to dry the skin after the rinsing step by dabbing the surface with a towel to leave the surface substantially dry to touch.
- the step of applying the leave-on composition after the rinsing off step may be carried out anywhere from a minute to an hour after the rinsing step.
- the step of applying the leave-on composition is from one minute to 30 minutes, more preferably one minute to 10 minutes, further more preferably from one minute to five minutes after the rinsing step.
- the method is non-therapeutic or cosmetic in nature.
- the invention also relates to a method of providing an SPF of 10, at least 20, preferably at least 30, more preferably at least 50, to the topical surface of the body.
- the method is non- therapeutic or cosmetic in nature.
- the invention also relates to a method of providing an LIVAPF of 4 to skin, of at least 8, preferably atleast 12, more preferably at least 16 to the topical surface of the body.
- the method is non-therapeutic or cosmetic in nature.
- a kit comprising a hand held container comprising a pump capable of generating a foam, said container comprising a wash-off composition comprising 0.1 to 10 wt% of a water-soluble UVA sunscreen; 0.1 to 10 wt% of a water-soluble UVB sunscreen; 3 to 80 wt%, preferably 6 to 80 wt% a mild surfactant selected from one or more of an anionic, zwitterionic or non-ionic surfactant; and a cosmetically acceptable carrier; a leave-on composition comprising a sunscreen and a cosmetically acceptable vehicle; and instructions for use.
- the use is non-therapeutic or cosmetic in nature.
- Wash off Compositions 1-2 The following skin cleansing compositions were prepared as shown in Table - 1 below:
- Leave-on Compositions 3-5: The following leave-on compositions were prepared as shown in Table - 2 below:
- the protocol used was as follows: A pre-wet vitro skin was applied with diluted wash-off product of Composition 1 or 2. The vitro skin was rinsed off immediately post product application and kept for drying in dark. After the drying step, vitro skin was exposed to UV light and transmittance scan was recorded. This scan gives the transmittance as a function of wavelength (290 - 400 nm) for a given sample. For a single vitro skin sample four different spots were scanned. The same was repeated for 2 vitro skin samples. The data reported is thus an average over 8 readings. The reference transmittance scan was obtained using blank vitro skin, with glycerine spread on it as control. The transmittance values were used to arrive at the SPF and UVA PF values using the software provided with the instrument.
- composition 3 or 4 or 5 leave-on product
- the vitro skin post washing with Composition 1 or 2 was applied with 2mg /cm 2 of leave-on product (Composition 3 or 4 or 5) on the same side of the vitro skin where cleansing was performed to mimic the consumer scenario.
- the vitro skin applied was then allowed to dry in the dark for 20-30 minutes to simulate recommended drying time from in vivo ISO 24444 methods.
- vitro skin was exposed to UV light and transmittance scan was recorded. This scan gives the transmittance as a function of wavelength (290 - 400 nm) for a given sample.
- For a single vitro skin sample four different spots were scanned. The same was repeated for 2 vitro skin samples. The data reported is thus an average over 8 readings.
- the reference transmittance scan was obtained using blank vitro skin, with glycerine spread on it as control. The transmittance values were used to arrive at the SPF and UVA PF values using the software provided with the instrument.
- Example - 1 The SPF and UVAPF of the substrate was measured after washing it with wash- off composition 1
- Example - 2 The SPF and UVAPF of the substrate was measured after washing it with wash- off composition 2
- Example - 3 The SPF and UVAPF of the substrate was measured after applying leave -on composition 3.
- Example - 4 The SPF and LIVAPF of the substrate was measured after applying leave -on composition 4.
- Example - 5 The SPF and LIVAPF of the substrate was measured after applying leave -on composition 5.
- Example- 6 The SPF and LIVAPF of the substrate was measured after washing substrate with composition 1 followed by applying leave -on composition 3.
- Example- 7 The SPF and LIVAPF of the substrate was measured after washing substrate with composition 1 followed by applying leave -on composition 4.
- Example- 8 The SPF and LIVAPF of the substrate was measured after washing substrate with composition 1 followed by applying leave -on composition 5.
- Example- 9 The SPF and LIVAPF of the substrate was measured after washing substrate with composition 2 followed by applying leave -on composition 3.
- Example- 10 The SPF and LIVAPF of the substrate was measured after washing substrate with composition 2 followed by applying leave -on composition 4.
- Example- 11 The SPF and LIVAPF of the substrate was measured after washing substrate with composition 2 followed by applying leave -on composition 5.
Abstract
The present invention relates to a method of delivering high Sun Protection Factor (SPF) and UVA protection factor (UVAPF) to a topical surface of a human body. The method provides for synergistic benefit of SPF and UVA PF over and above that which can be delivered through each of two individual steps carried out sequentially viz. a washing off step followed by the step of applying a leave on composition on to the same skin surface. The method comprises washing the skin with a foam composition generated from a container comprising a pump, the foam composition comprising a water soluble sunscreen followed by applying a leave-on composition which could comprise any sunscreen.
Description
A METHOD OF PROVIDING HIGH SPF TO A TOPICAL SURFACE OF A BODY
Field of the Invention
The present invention relates to a method of delivering high Sun Protection Factor (SPF) to a topical surface of a body preferably the human body. The method more preferably provides for synergistic benefit of SPF over and above that which can be delivered through each of two individual steps carried out sequentially viz. washing of the skin with a specific cleansing foam composition delivered from a container with a pump followed by the step of applying a sunscreen composition on to the same skin surface.
Background of the Invention
Solar radiation includes about 5% ultraviolet (UV) radiation, wavelength of which is between 200 nm and 400 nm. It is further classified into three regions: from 320 to 400 nm (UV-A), 290 to 320 nm (UV-B) and from 200 to 290 nm (UV-C). Exposure to UV-A and UV-B radiation for short period is known to cause reddening of the skin and localized irritation. Continued and prolonged exposure can lead to sunburn, melanoma and formation of wrinkles. It is also reported that UV radiation causes significant damage to hair. Therefore, people desire to protect their skin and hair from the harmful effects of both UV-A and UV-B radiation.
Various cosmetic preparations that one can apply on to the skin such as creams, lotions or gels have been reported for preventing and/or protecting the skin from harmful effects of ultraviolet radiation. These cosmetic compositions usually comprise different types of organic sunscreen agents, especially ones capable of absorbing the UV-A and/or UV-B radiation present in the sun’s rays. Thus, both UV-A and UV-B sunscreens are usually incorporated in photo-protective compositions so as to provide protection over the entire range of UV radiation. Such leave-on compositions are applied on to skin before a person goes outdoors and they remain thereon till the person has a next wash.
An alternate method of application of sunscreens on the skin is through wash-off products like soaps, face wash or body wash products where the sunscreens are incorporated in the skin cleansing products and are delivered on to the skin concurrent with the washing process. However, it is an extremely difficult challenge to deliver sunscreens on to skin when the primary purpose of wash-off products is to remove the dirt and oils from the skin surface and together
with that, the actives in the wash-off products are also highly likely to get washed away. Thus, enhanced deposition of actives through wash-off products is an on-going challenge.
The present inventors with their years of experience in understanding the nature of available sunscreens; the knowledge of interfacial science of surfactant systems and through extensive experimentation set out find a solution to the problem of delivering high SPF on to skin. They hit upon a unique two step method that provides for synergistic improvement in SPF as compared to each of the steps individually. The method comprises the step of washing the skin with a foam composition comprising water soluble sunscreens which is generated from a container fitted with a foam generating pump; followed by the step of applying a leave-on sunscreen composition on to skin.
EP1261688 (Unilever, 2001) discloses a personal wash composition which deposits high levels of sunscreen (SPF>2) while maintaining good lather (i.e. suffer minimal lather degradation over time relative to compositions with more “oily” sunscreens). Enhanced deposition is found from both bar and liquid compositions and is based on the solubility or non-solubility of the sunscreen used.
The present inventors have found that there is a limit to the SPF that can be achieved with either a wash-off sunscreen composition or a leave-on sunscreen composition, the latter being more efficacious. Incorporation of higher amount of sunscreens as taught in the prior art does not, in general, provide for continuous increase+ in the deposition efficacy and thereby the SPF achieved.
It is therefore an object of the present invention to obviate at least some drawbacks of the prior art and provide a method which delivers enhanced and even synergistic SPF as compared to the known art.
It is another object of the present invention to provide for a method that provides SPF of higher than 10 and a UVAPF (UV-A protection factor) of higher than 4.
Summary of the Invention
According to the first aspect of the present invention, there is provided a method of providing high SPF to a topical surface of a body comprising the steps of
(a) washing the surface with a wash-off composition generated as a foam from a container comprising a pump, said wash-off composition comprising
(i) 0.1 to 10 wt% of a water-soluble UVA sunscreen;
(ii) 0.1 to 10 wt% of a water-soluble UVB sunscreen;
(iii) 3 to 80 wt%, preferably 6 to 80 wt% a mild surfactant selected from one or more of an anionic, zwitterionic and non-ionic surfactant; and
(iv) a cosmetically acceptable carrier; preferably diluted with water followed by
(b) rinsing said surface with water; followed by
(c) applying a leave-on composition comprising a sunscreen and a cosmetically acceptable vehicle, on said surface.
The second aspect of the present invention relates to a kit comprising
(a) a hand held container comprising a pump capable of generating a foam, said container comprising a wash-off composition comprising 0.1 to 10 wt% of a water-soluble UVA sunscreen; 0.1 to 10 wt% of a water-soluble UVB sunscreen; 3 to 80 wt%, preferably 6 to 80 wt% a mild surfactant selected from one or more of an anionic, zwitterionic or non-ionic surfactant; and a cosmetically acceptable carrier;
(b) a leave-on composition comprising a sunscreen and a cosmetically acceptable vehicle; and
(c) Instructions for use.
Detailed Description of the Invention
These and other aspects, features and advantages will become apparent to those of ordinary skill in the art from a reading of the following detailed description and the appended claims. For the avoidance of doubt, any feature of one aspect of the present invention may be utilized in any other aspect of the invention. The word “comprising” is intended to mean “including” but not necessarily “consisting of’ or “composed of.” In other words, the listed steps or options need not be exhaustive. It is noted that the examples given in the description below are intended to clarify the invention and are not intended to limit the invention to those examples per se. Similarly, all percentages are weight/weight percentages unless otherwise indicated. Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description and claims indicating amounts of material or conditions of reaction, physical properties of materials and/or use are to be understood as modified by the word “about”. Numerical ranges expressed in the format "from x to y" are understood to include x and y. When for a specific
feature multiple preferred ranges are described in the format "from x to y", it is understood that all ranges combining the different endpoints are also contemplated.
The disclosure of the invention as found herein is to be considered to cover all embodiments as found in the claims as being multiply dependent upon each other irrespective of the fact that claims may be found without multiple dependency or redundancy. Where a feature is disclosed with respect to a particular aspect of the invention (for example a method of the invention), such disclosure is also to be considered to apply to any other aspect of the invention (for example a kit of the invention) mutatis mutandis. Preferably, the method or the use is non-therapeutic or cosmetic in nature.
By “a wash-off composition” as used herein, is meant to include a composition for cleaning topical surfaces of mammals, especially humans. This composition is particularly useful for use on the sun-exposed parts of the body. Such a composition is generally of the rinse off type which means that the composition is high in surfactants which are known to help in cleaning surfaces to make them free of oils and dirt. The wash-off composition is generally used by diluting with water as it is applied on to skin, scalp or hair, after which the consumer works up a lather to ensure that the dirt and oil on the surface are solubilized in the micelles of the surfactant solution and the body is then rinsed with copious amounts of water to ensure that the surface is substantially free of the composition. The wash-off composition of the present invention is included in a container that is fitted with a pump. When the pump on the container is actuated, the composition issues as a foam from the container which is then used by the consumer for washing the desired surface of the body. “Skin” as used herein is meant to include skin on the face and body (e.g., neck, chest, back, arms, underarms, hands, legs, buttocks and scalp) and especially to the sun exposed parts thereof. The wash-off composition of the invention is also of relevance to application on any other keratinous substrates of the human body other than skin e.g. scalp and hair where products may be formulated with specific aim of providing photo-protection. It has been observed that with the use of the wash-off composition of the method of the present invention, the dirt and oil on the skin surface are substantially removed during the washing and rinsing process. Further, surprisingly, the specific combination of the sunscreens incorporated ensures that they deposit in much higher amounts than is generally expected from rinse off products, in such a way that the deposited sunscreens interact synergistically with the sunscreens applied thereafter from the leave-on composition to provide the enhanced SPF and LIVAPF benefit. The enhanced deposition leads to delivering high Sun Protection Factor (SPF). By high SPF as per this invention is meant a composition that preferably has an SPF at least 10, more preferably at least 15, more preferably
higher than 20, further more preferably higher than 30, yet more preferably higher than 50, in many cases higher than 80, and in optimum cases higher than 100. Most preferably the invention provides for SPF in the range of 20 to 50. The SPF could be as high as 160. The SPF in the present invention is measured using transmittance measurement technique. The method of the invention also delivers high LIVAPF. By high LIVAPF is meant that the method delivers II VAPF(initiai) of at least 4, preferably higher than 8, further preferably higher than 12, further more preferably higher than 16, and most preferably higher than 20. In especially preferred aspects, the present invention delivers LIVAPF value in the range of 4 to 16. The LIVAPF could be as high as 40.
The wash-off composition which is used in the first step of the method of the invention comprises 0.1 to 10 wt% of a water-soluble UVA sunscreen; 0.1 to 10 wt% of a water-soluble UVB sunscreen; 3 to 80 wt%, preferably 6 to 80 wt% a mild surfactant selected from one or more of an anionic, zwitterionic and non-ionic surfactant; and a cosmetically acceptable carrier.
By water soluble sunscreen, whether of the UVA type, or of the UVB type, is meant that the solubility in water of the sunscreen is higher than 10 g/l preferably higher than 50 g/l at 25 °C. The wash-off composition is included in a container. The container is preferably capable of being hand-held. The container comprises a pump at its head such that on actuation of the pump by pressing down with a finger or a thumb the composition mixes with air and issues from the container as a foam. The various ways in which the container with the pump could be delivered are described below.
The container comprises a sprayable foamable composition. It may be delivered using a spray device that contains the foamable composition. The spray device may comprise a bottle having a nozzle and a spray pump dispenser. The invention thus provides a cleaning system comprising a spraying device. The spraying device comprises a container holding the foamable wash-off composition, a spray head, and a liquid supply arrangement for transferring the foamable wash- off composition from the container to the spray head to form the foam. The foam generated generally has a density of less than 0.4 g/ml when ejected from the spray device through the spray head.
The spraying device used in the present invention preferably comprises a container having an internal volume of 25 to 1000 ml, more preferably of 50 to 800 ml, even more preferably 60 to 750 ml and most preferably of 75 to 500 ml. The spraying device preferably comprises a positive
displacement pump that acts directly on the foamable wash-off composition. The pump draws the composition up into the liquid supply arrangement and transfers the composition to the spray head, from which it is discharged in the form of a foam, preferably through a nozzle.
In the spraying device the dispensing of the wash-off composition is preferably powered by a user's efforts, i.e, the liquid cleaning composition is not dispensed under pressure by simply actuating a valve and requires manual triggering. The spraying device employed in accordance with the present invention is preferably selected from a trigger spray foam bottle, a squeeze foam bottle and a foam pump. Most preferably the spraying device is a squeeze foam bottle or a foam pump. In another preferred embodiment, the spray device is configured to mix the liquid cleaning composition with air before it is dispensed from the spray head. The composition can be placed into the reservoir of a plastic squeeze bottle which contains a foaming spray head or other foam producing means. Squeezing the container causes the wash-off composition to leave the reservoir and enter an air-mixing or foaming chamber via an internal dip tube. The foam produced in the foaming chamber is often passed through a homogenizing element interposed between the air-mixing chamber and the discharge orifice to homogenise and control the consistency of the discharged foam. Further compression of the foam discharges the foam from a discharge cap as a uniform non-pressurised aerated foam. Alternatively the side walls of the container may be rigid and the dip tube may be fitted with a pump that is actuated by a push button. When composition is drawn by the pump through to the air mixing or foaming chamber, the desired foam is produced.
The preferred UVB sunscreen for use in the wash-off composition is phenyl benzimidazole sulphonic acid (PBSA) or benzylidene camphor sulfonic acid, preferably PBSA.
2-Phenylbenzimidazole 5-sulfonic acid
PBSA also known as Ensulizole is commercially available as Eusolex 232 (from Merck KGaA). PBSA is also available under the brand names Neo Heliopan Hydro (from Symrise), Parsol HS (from DSM) and Sunsafe ES (from Uniproma). It is generally used in the water solubilized form after neutralization to deliver desired benefit.
Benzylidene camphor sulfonic acid has the chemical structure: It is generally used in the water solubilized form pre/post neutralization to deliver desired benefit.
The preferred UVA sunscreen for use in the wash-off composition is one or more of disodium phenyl dibenzimidazole tetrasulfonate (Neoheliopan AP) or terephthalylidene dicamphor sulfonic acid (TDSA).
Di sodium phenyl dibenzimidazole tetra sulfonate also known as bisdisulizole disodium has the chemical structure as given below:
This is commercially available as Neo heliopan AP (from Symrise Shanghai Ltd) or as Sunsafe DPDT (from Uniproma). It is generally used in the water solubilized form after neutralization to deliver desired benefit.
Terephthalylidene dicamphor sulfonic acid (TDSA) has the structure
It is also known as Ecamsule. This is commercially available as Mexoryl SX (US4585597) by L’ Oreal or Sunsafe TDSA (from Uniproma). It can be used as parent acid or its salts in water solubilized form to deliver the desired benefit.
The wash-off composition preferably comprises 0.1 to 10 wt%, more preferably 0.25 to 8 wt%, even more preferably 0.5 to 5% water soluble UVA sunscreen. The composition preferably comprises 0.1 to 10 wt%, more preferably 0.25 to 8 wt%, even more preferably 0.5 to 5% water soluble UVB sunscreen. There are certain sunscreens which have both a UVA screening efficacy as well as a UVB screening efficacy. Such sunscreens provide both UVA and UVB protection e.g. benzophenone-4. Benzophenone-4 (Sulisobenzone) has the chemical structure:
Such sunscreens may also be included in the wash-off composition of the invention. When included, it is to be understood that it is taken as having included one type of sunscreen i.e. either a UVA sunscreen or a UVB sunscreen and not both. Thus, when included as a UVA sunscreen, it is essential to include another sunscreen as a UVB sunscreen. Similarly, when included as a UVB sunscreen, it is essential to include another sunscreen as a UVA sunscreen.
The water-soluble sunscreens for inclusion in the wash-off composition of the present invention are generally commercially available in the acid form. When included in the composition in the acid form (pre /partially neutralized forms) i.e. having sulphonic acid group (-SO3H) the wash-off composition additionally comprises a neutralising agent to convert the acid form into the salt form, in which form it is known to be active as a sunscreen with an exception to Mexoryl SX which can act as sunscreen with and without neutralization. When included, the neutralising agent is preferably in 0.05% to 4% by weight of the composition. The neutralising agent is preferably an inorganic or an organic alkali. Organic alkali is preferably an amine such as triethanol amine or diethanol amine. The present inventors have observed that the inorganic alkali is especially preferred. Preferred are alkali metal hydroxides. Most preferred metal hydroxide for inclusion as neutralising agent in the composition of the invention are sodium hydroxide or potassium hydroxide.
One of the objects of the first step of the method of the invention is to ensure that the sunscreen is deposited in as high an amount as possible on the skin through the wash-off process. Without wishing to be bound by theory, the inventors believe that this is achieved through the select combination of sunscreens chosen by their structure and solubility in the select foaming surfactant composition which determine their partition between rinse away water and cleansing surface resulting in high sunscreen deposition.
The wash-off composition of the invention comprises a mild surfactant which is delivered in the form of a foam which aids in the cleaning action. To enable cleaning, the mild surfactant is included in 3 to 80% preferably 6 to 80%, further more preferably 10 to 75% by weight of the composition. By a mild surfactant is meant that the Zein Number is less than 100 or or has a value of less than 6% zein dissolution weight %. The Zein dissolution wt% is defined in the reference US9655866B2 “Mild antibacterial cleansing compositions”.
The mild surfactant is preferably an anionic surfactant which is selected from one or more of an isethionate, glycinate, cocoate, olefin sulphonate, sulphoacetate and sulphosuccinate surfactant. Preferred mild anionic surfactants are chosen from one or more of sodium cocoyl isethionates, potassium cocoyl glycinate and potassium cocoate, alpha olefin sulphonate (AOS), sodium lauryl sulfoacetate, alkyl ether sulfoacetates, sodium dioctylsulphosuccinate, and alkyl ether sulfosuccinates. These anionic surfactants are preferably present at a level of from 1 to 50%, preferably 2 to 35%, further more preferably from 10 to 35% by weight of the wash-off composition.
The wash-off composition of the invention preferably comprises a mild amphoteric surfactant which may be chosen from one or more of cocoamidopropyl hydroxysultaine, coco amidopropyl betaine, sodium lauroamphoacetate and sodium cocoamphoacetate.
When included the wash-off composition comprises from 0.1 to 10 wt.%, preferably from 0.5 to 8 wt.%, more preferably from 1 to 5 wt.% of the mild amphoteric surfactant.
The wash-off composition of the invention preferably comprises a mild non-ionic surfactant which may be chosen from one or more of Polysorbate 20, Polysorbate 60, sorbitan laurate, decyl glucoside, and lauryl glucoside.
When included the wash-off composition comprises more than 0.5 but less than 30%, preferably from 1 to 20 % by weight of the mild non-ionic surfactant.
The wash-off composition of the invention comprises a cosmetically acceptable carrier. The cosmetically acceptable carrier is preferably an aqueous solution/ dispersion of cosmetically acceptable adjuvents. Water is generally included in the wash-off composition of the invention. The wash-off composition is generally formulated in liquid, emulsion or gel form where the water content is generally in the range of 50 to 95%, preferably in the range of 60 to 85% by weight of the composition.
Additional adjuvents which may be used to make up the cosmetically acceptable carrier of the wash-off composition are described below.
The wash-off composition preferably comprises a polyhydric alcohol (also called polyol) or mixture of polyols. Polyol is a term used herein to designate a compound having multiple hydroxyl groups (at least two, preferably at least three) which is highly water soluble. Many types of polyols are available including: relatively low molecular weight short chain polyhydroxy compounds such as glycerol and propylene glycol; sugars such as sorbitol, manitol, sucrose and glucose; modified carbohydrates such as hydrolyzed starch, dextrin and maltodextrin, and polymeric synthetic polyols such as polyalkylene glycols, for example polyoxyethylene glycol (PEG) and polyoxypropylene glycol (PPG). Especially preferred polyols are glycerol, sorbitol and their mixtures. Most preferred polyol is glycerol. In a preferred embodiment, the bars of the invention comprise 0 to 8%, preferably 1 to 7.5% by wt. polyol
A preferred wash-off composition may additionally include up to 30 wt% benefit agents. Preferred benefit agents include moisturizers, emollients, and anti-ageing compounds.
Other optional ingredients like anti-oxidants, perfumes, polymers, chelating agents, colourants, deodorants, dyes, enzymes, foam boosters, germicides, anti-microbials, lathering agents, pearlescers, skin conditioners, stabilizers or superfatting agents, may be added in suitable amounts in the process of the invention. Preferably, the ingredients are added after the saponification step. Sodium metabisulphite, ethylene diamine tetra acetic acid (EDTA), borax or ethylene hydroxy diphosphonic acid (EH DP) are preferably added to the formulation.
The present invention includes a second step of the method which comprises applying a leave- on composition comprising a sunscreen and a cosmetically acceptable vehicle on to the desired topical surface e.g a skin surface. By a leave-on composition is meant a composition that is applied on the desired topical surface and left thereon till such time that the surface is cleaned usually after several hours or after one day when a person normally has his bath or shower or any other personal cleansing routine. The leave-on composition of the present invention can be in the form of a liquid, lotion, cream, spray, stick or gel. “Skin” as used herein is meant to include skin on the face and body (e.g., neck, chest, back, arms, underarms, hands, legs, buttocks and scalp) and especially to the sun exposed parts thereof. The leave-on composition of the invention is also of relevance to application on any other keratinous substrates of the human body other than skin e.g. scalp and hair where products may be formulated with specific aim of providing photo-protection.
The sunscreen in the leave-on composition is an organic UVA sunscreen, an organic UVB sunscreen, an inorganic sunblock or mixtures thereof preferably a combination of an organic UVB sunscreen and an organic UVA sunscreen.
Preferably, the leave-on composition comprises a UVA organic sunscreen that absorbs UVA radiations and prevent them from reaching a surface e.g. skin of a user. Examples of sunscreens that may be used as UVA organic sunscreen in the composition are dibenzoylmethane compound, bisdisulizole disodium (commercially available as Neo Heliopan® AP), diethylamino hydroxybenzoyl hexyl benzoate (commercially available as Uvinul® A Plus), Ecamsule (commercially available as Mexoryl SX), Dimethoxyphenyl-[1-(3,4)]-4,4-dimethyl 1 ,3- pentanedione, and Methyl anthranilate. Preferably, sunscreen that may be used as UVA organic sunscreen in the leave-on composition is selected from a dibenzoylmethane compound or diethylamino hydroxy benzoyl hexyl benzoate, preferably a dibenzoylmethane compound.
Examples of sunscreen of dibenzoymethane compound that may be used as UVA organic sunscreen in the leave-on composition include butyl methoxydibenzoylmethane or BMDM (commercially available as Parsol® 1789 or Avobenzone), 2-methyldibenzoylmethane, 4- isopropyldibenzoyl-methane, 4-tert-butyldibenzoylmethane, 2,4-dimethyldibenzoylmethane, 2,5- dimethyldibenzoylmethane, 4,4'-diisopropyl-dibenzoylmethane, 2-methyl-5-isopropyl-4'- methoxydibenzoylmethane, 2-methyl-5-tert-butyl-4'-methoxy-dibenzoyl methane, 2,4-dimethyl- 4'-methoxy dibenzoylmethane or 2,6-dimethyl-4-tert-butyl-4'-methoxy-dibenzoylmethane. Most preferably, dibenzoylmethane compound that may be used as UVA organic sunscreen is BMDM.
Preferably, the leave-on composition comprises from 0.01 to 10 wt%, more preferably from 0.1 to 8 wt%, even more preferably from 1 to 6 wt%, further more preferably 1 to 5 wt%, still more preferably from 1 to 3 wt%, yet more preferably from 1 to 2.5 wt% of one or more UVA organic sunscreens.
Preferably, the leave-on composition may comprise a UV-B organic sunscreen. UVB organic sunscreens absorb UVB radiations and prevent them from reaching a surface e.g. skin of a user. Examples of UVB organic sunscreens that may be used in the composition include compounds from the class of cinnamic acid, salicylic acid, diphenyl acrylic acid, Benzylidene camphor and derivatives thereof. Examples of such compounds include 2-ethylhexyl salicylate (commercially available as Octisalate™), 3,3,5-Trimethylcyclohexyl 2-hydroxybenzoate (commercially available as Homosalate™), Ethylhexyl Methoxycinnamate (commercially available as NeoHelipan® AV), 2-ethylhexyl 2-cyano-3,3-diphenylacrylate (OCR; commercially available as Octocrylene™), 2- Hydroxy-4-methoxybenzophenone (commercially available as Oxybenzone™), 2-ethyl-hexyl-4- methoxy cinnamate (MCX; commercially available as Parsol MCX™), 3-Benzylidene camphor, Benzylidene camphor sulfonic acid, DEA methoxycinnamate, Cinoxate, Diethylhexyl butamido triazone, Digalloyl trioleate, Diisopropyl methyl cinnamate, Ethyl dihydroxypropyl PABA, Ethylhexyl dimethoxy benzylidene dioxoimidazoline propionate, Ethylhexyl dimethyl PABA , Ethylhexyl triazone, Ferulic acid, Glyceryl ethylhexanoate dimethoxycinnamate, Glyceryl PABA, Isoamyl p-methoxycinnamate , Isopentyl trimethoxycinnamate trisiloxane, Isopropyl benzyl salicylate, Isopropyl methoxycinnamate, 4-Methylbenzylidene camphor, PABA, PEG-25 PABA, Pentyl dimethyl PABA, Phenyl benzimidazole sulfonic acid, Polyacrylamido methylbenzylidene camphor, Polysilicone-15, Salicylic acid, TEA salicylate and mixtures thereof. Preferably, UVB organic sunscreens that may be used in the leave-on composition are selected from OCR, MCX. phenyl benzimidazole sulphonic acid, ethyl hexyl salicylate and mixtures thereof.
When incorporated in the composition, UVB organic sunscreens may preferably be incorporated from 0.1 to 10 wt%, more preferably from 0.5 to 7 wt%, even more preferably from 1 to 5 wt%, further more preferably from 1 to 3.5 wt%, yet more preferably from 1 to 3 wt%, still more preferably 1 to 2.5 wt% in the leave-on composition.
Preferably, the leave-on composition may comprise a LIVB/A sunscreen which are sunscreens that absorb both UVB and UVA radiations and prevent them from reaching the applied surface. Examples of UVB/ A sunscreens that may be used in the composition include Benzophenone derivatives. Examples of such compounds are Benzophenone-1 , Benzophenone-2, Benzophenone-3, Benzophenone-4, Benzophenone-5, Benzophenone-6, Benzophenone-8, Benzophenone-9, Beta-2-Glucopyranoxy propyl hydroxy benzophenone, Bisethylhexyloxyphenol methoxyphenyl triazine (Tinosorb S), Drometrizole, Drometrizole trisiloxane, Methylene bis-benzotriazolyl tetramethylbutylphenol (Tinosorb M).
Preferably, the leave-on composition comprises from 0.01 to 10 wt%, more preferably from 0.1 to 8 wt%, even more preferably from 1 to 6 wt%, further more preferably 1 to 5 wt%, still more preferably from 1 to 3 wt%, yet more preferably from 1 to 2.5 wt% of one or more UVB/A organic sunscreens.
Preferably, the composition may comprise an inorganic sunblock. Examples of inorganic sunblock that may be used in the composition include zinc oxide (ZnO), iron oxide, silica, such as fumed silica and titanium dioxide (TiO2). Preferably, inorganic sunblock that may be used in the composition are selected from TiC ZnO and mixtures thereof.
When incorporated the composition, inorganic sunblock may preferably be incorporated from 0.1 to 25% wt%, more preferably from 0.5 to 20 wt%, even more preferably from 1 to 15 wt%, further more preferably from 1 to 10 wt%, yet more preferably from 1 to 5 wt%, still more preferably 1 to 3 wt%, in the composition.
The leave-on composition may comprise one or more agents for providing glow to the skin. Examples of the agents include niacinamide, picolinamide, 4-alkyl substituted resorcinol, vitamin B6, vitamin C, vitamin A, glutathione precursors, galardin, adapalene, aloe extract, ammonium lactate, arbutin, azelaic acid, butyl hydroxy anisole, butyl hydroxy toluene, citrate esters, deoxyarbutin, 1 ,3-diphenyl propane derivatives, 2,5-dihydroxybenzoic acid and its derivatives, 2- (4-acetoxyphenyl)-1 ,3-dithiane, 2-(4-hydroxyphenyl)-1 ,3-dithiane, ellagic acid, gluco pyranosyl-
1 -ascorbate, gluconic acid, glycolic acid, green tea extract, 4-Hydroxy-5-methyl-3[2H]-furanone, 4-hydroxyanisole and its derivatives, 4-hydroxybenzoic acid derivatives, hydroxycaprylic acid, inositol ascorbate, lactic acid, lemon extract, linoleic acid, magnesium ascorbyl phosphate, 5- octanoyl salicylic acid, salicylic acid, 3,4,5-trihydroxybenzyl derivatives, acetylglucosamine, pitera extract, symwhite, calcium pantothenate (Melano-block), seppiwhite, soybean extract (bowman birk inhibitor), 12- hydroxy stearic acid and mixtures thereof. When used in the composition, 12- hydroxystearic acid is used as a skin glow agent and not as a fatty acid.
Preferably, the agent for providing glow to the skin is selected from the group consisting of niacinamide, picolinamide, isonicotinamide, 12-hydroxystearic acid, 4-alkyl substituted resorcinol and mixtures thereof. Preferably the skin glow agent used in the leave-on composition is niacinamide. More preferably, the skin glow agent selected is 4-alkyl substituted resorcinol selected from the group consisting of 4-ethyl resorcinol (4-ER), 4-isopropyl resorcinol (4-IPR), 4- butyl resorcinol (4-BR), 4-pentyl resorcinol(4-PR), 4-phenylethyl resorcinol (4-PER), 4-HR and mixtures thereof. Even more preferably, the agent is selected from the group consisting of 4-ER, 4-HR and mixtures thereof. Further more preferably, the agent selected is 4-HR.
Preferably, the leave-on composition comprises from 0.001 to 10 wt%, more preferably from 0.01 to 8 wt%, even more preferably from 0.1 to 7 wt%, further more preferably from 0.1 to 5 wt%, still more preferably from 0.1 to 3 wt%, yet more preferably from 0.1 to 1 wt% and still further more preferably from 0.25 to 0.5 wt% of a skin glow agent.
The leave-on composition comprises a cosmetically acceptable vehicle. The cosmetically acceptable vehicle is preferably in the form of an oil, liquid, stick, cream, lotion, spray or gel. The cosmetically acceptable vehicle preferably includes ingredients like surfactant e.g. non-ionic surfactant, fatty acid, soap, water, polymer, emollients, solvents, powders, preservatives, or optional ingredients. Details on the various possible ingredients for inclusion in the cosmetically acceptable vehicle are given below.
Preferably, the leave-on composition comprises a nonionic surfactant. More preferably the nonionic surfactant is selected from those having HLB value in the range 9 to 20, preferably 10 to 19, more preferably 12 to 18, even more preferably 13 to 17 and yet more preferably 15 to 17.
HLB is calculated using the Griffin method wherein HLB = 20 x Mh / M wherein Mh is the molecular mass of the hydrophilic portion of the molecule and M is the molecular mass of the whole molecule, giving a result on an arbitrary scale of 0 to 20. Typical values for various surfactants are given below:
A value <10 : Lipid soluble (water insoluble)
A value >10 : Water soluble
A value from 4 to 8 indicates an anti-foaming agent
A value from 7 to 11 indicates a W/O (water in oil) emulsifier
A value from 12 to 16 indicates oil in water emulsifier
A value from 11 to 14 indicates a wetting agent
A value from 12 to 15 is typical of detergents
A value of 16 to 20 indicates a solubiliser or a hydrotrope.
Preferably, the nonionic surfactant having HLB value in the range 9 to 20 is selected from fatty alcohol ethoxylates, alkyl phenol ethoxylates, polyoxyethylene sorbitan alkyl esters and mixtures thereof. Preferably, the nonionic surfactants are ones with at least 9 alkylene oxide groups preferably at least 9 ethylene oxide groups.
Examples of fatty alcohol ethoxylates that may be used as nonionic surfactants in the composition include polyoxyethylene lauryl ether (HLB= 16.9; commercially available as Brij® 35), polyoxyethylene (20) cetyl ether (HLB=16; commercially available as Brij® 58), polyethylene glycol octadecyl ether (HLB= 18.8; commercially available as Brij® 700) and Laureth - 9 (C12EO9; HLB=14.3; commercially available as Brij® L9).
Examples of alkyl phenol ethoxylates that may be used as nonionic surfactant in the composition include octylphenol ethoxylate (HLB=15.5; commercially available as Triton™ X165), octylphenol ethoxylate (HLB=17.6; commercially available as Triton™ X405) and octylphenol ethoxylate (HLB=18.4; commercially available as Triton™ X705).
Examples of polyoxyethylene sorbitan alkyl esters that may be used as the nonionic surfactant in the composition include polyoxyethylenesorbitan monolaurate (HLB=13.3; commercially available as Tween® 21), polyoxyethylenesorbitan monolaurate (HLB=16.7; commercially available as Tween® 20), Polyoxyethylenesorbitan monopalmitate (HLB=15.6; commercially available as Tween® 40) and polyoxyethylene sorbitan monostearate (HLB= 14.9; commercially available as Tween® 60).
Even more preferably, the nonionic surfactant having HLB value in the range 9 to 20 that may be present in the composition is fatty alcohol ethoxylate with saturated carbon chain having HLB higher than 15.5.
Preferably, the leave-on composition comprises 0.5 to 5 wt%, more preferably 1 to 4 wt%, even more preferably from 2 to 3 wt% nonionic surfactant having HLB in the range 9 to 20.
Preferably, the leave-on composition comprises fatty acid. Fatty acids when present in a composition along with a soap provides the so-called vanishing cream effect, i.e. a composition, when applied on to the human skin, vanishes on the skin leaving behind no significant streaks of the composition. Preferably, the leave-on composition comprises fatty acids having 10 to 30, more preferably 12 to 25, even more preferably 14 to 20, further more preferably 16 to 18 carbon atoms. Examples of fatty acids that may be used in the composition include pelargonic, lauric, myristic, palmitic, stearic, isostearic, oleic, linoleic, arachidic, behenic, erucic acid and mixtures thereof. Preferably, the fatty acid that may be used is stearic acid or palmitic acid or a mixture thereof. The fatty acid in the present invention is preferably hystric acid which is substantially (generally about 90 to 95%) a mixture of stearic acid and palmitic acid in a ratio of between 55:45 to 45:55.
Preferably, the leave-on composition comprises from 2.25 to 25 wt%, more preferably from 4 to 22 wt%, even more preferably from 6 to 20 wt%, further more preferably from 8 to 19 wt% and still more preferably from 10 to 18 wt% and yet more preferably from 12 to 16 wt% fatty acid.
Preferably, the leave-on composition comprises soap. Soap, when present in combination with fatty acid in the composition, provides the vanishing cream effect. Preferably, soap in the leave- on composition is generally prepared by in-situ neutralization of fatty acid that may be present in the composition. Thus, it is preferred that the soap has a carbon chain length that corresponds to the chain length of fatty acid in the composition. The soap is formed from the fatty acid through use of alkali metal hydroxides e.g. sodium hydroxide or potassium hydroxide. Of the two, potassium hydroxide is more preferred. Thus, the soap is preferably a potassium soap (potassium salt of fatty acid).
Preferably, the leave-on composition comprises from 0.1 to 10 wt%, more preferably from 0.25% to 8 wt%, even more preferably from 0.5 to 7 wt%, further more preferably from 0.5 to 5 wt% soap, even further more preferably 0.5% to 3%.
Preferably, the leave-on composition comprises water in amount from 5 to 99.9 wt%, more preferably from 10 to 95 wt%, even more preferably from 15 to 90 wt%, further more preferably from 20 to 80 wt%, still more preferably 25 to 75 wt% and yet more preferably 30 to 70 wt%.
Preferably, the leave-on composition comprises a polymer. The polymer acts as thickener in the composition and improves sensorial properties of the composition.
The polymer is preferably selected from the following classes: acrylate I R-methacrylate copolymer e.g. acrylates/ steareth-20 methacrylate copolymer (commercially available as Aculyn™ 22) and acrylates/ beheneth-25 methacrylate copolymer (commercially available as Aculyn™ 28), acrylate I R-methacrylate crosspolymer e.g. acrylates/steareth-20 methacrylate crosspolymer (commercially available as Aculyn™ 88), acrylates copolymer (commercially available as Aculyn™ 33), acrylate/R-alkyl acrylate crosspolymer e.g. acrylates/C10-C30 alkyl acrylate crosspolymer (commercially available as Pemulen™ TR-2), copolymer of ammonium acryloyldimethyltaurate with vinyl pyrrolidone (commercially available as Aristoflex® AVC), copolymer of sodium acryloyldimethyltaurate with vinyl pyrrolidone (commercially available as Aristoflex® AVS); and crosspolymer of acryloyldimethyltaurate with R-alkyl acrylate and methyacrylate e.g. Ammonium acryloyldimethyltaurate/ beheneth-25 methacrylate crosspolymer (commercially available as Aristoflex® HMB and Aristoflex® BLV).
Preferably, the leave-on composition comprises 0.1 to 5 wt%, more preferably 0.25 to 4.5 wt%, even more preferably 0.5 to 4 wt%, further more preferably from 0.75 to 3.5 wt%, still more preferably from 0.75 to 2.75 wt% polymer.
Preferably, the leave-on composition comprises emollients. Examples of emollients that may be used in the leave-on composition include stearyl alcohol, glyceryl monoricinoleate, mink oil, cetyl alcohol, isopropyl isostearate, isobutyl palmitate, isocetyl stearate, oleyl alcohol, isopropyl
laurate, hexyl laurate, decyl oleate, octadecan-2-ol, isocetyl alcohol, eicosanyl alcohol, behenyl alcohol, cetyl palmitate, silicone oils such as dimethylpolysiloxane, din-butyl sebacate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, butyl stearate, polyethylene glycol, triethylene glycol, lanolin, cocoa butter, corn oil, cotton seed oil, olive oil, palm kernel oil, rape seed oil, safflower seed oil, evening primrose oil, soybean oil, sunflower seed oil, avocado oil, sesame seed oil, coconut oil, arachis oil, castor oil, acetylated lanolin alcohols, petroleum jelly, mineral oil, butyl myristate, isopropyl linoleate, lauryl lactate, myristyl lactate, decyl oleate, myristyl myristate and mixtures thereof.
Preferably, the leave-on composition comprises solvents. Examples of solvents that may be used in the composition include ethyl alcohol, isopropanol, acetone, ethylene glycol ono ethyl ether, diethylene glycol mono butyl ether, diethylene glycol mono ethyl ether and mixtures thereof.
Preferably, the leave-on composition comprises powders. Examples of powders that may be used in the composition include chalk, talc, fullers earth, kaolin, starch, gums, colloidal silica sodium polyacrylate, tetra alkyl and/or trialkyl aryl ammonium smectites, chemically modified magnesium aluminium silicate, organically modified montmorillonite clay, hydrated aluminium silicate, fumed silica, carboxyvinyl polymer, sodium carboxymethyl cellulose, ethylene glycol monostearate and mixtures thereof.
Preferably, the leave-on composition comprises preservatives to protect against the growth of potentially harmful microorganisms. Examples of ingredients that may be used as preservatives in the composition include alkyl esters of para-hydroxybenzoic acid, hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds. More preferably, ingredients that may be used as preservative in the composition are sodium benzoate, iodopropynyl butyl carbamate, methylisothiazolinone, iodopropynylbutylcarbamate, phenoxyethanol, methyl paraben, propyl paraben, imidazolidinyl urea, sodium dehydroacetate, ethylhexylglycerin, benzyl alcohol, alkane diols and mixtures thereof. The alkane diols that are suitable for use as preservative are C6-C12 alkanes that are vicinally substituted with hydroxy groups. Illustrative examples include 1 ,2-octane diol (caprylyl glycol), 2,3-octane diol, 1 ,2-nonane diol, 1 ,2-decane diol, 1 ,2-hexane diol, 3,4-octane diol, mixtures thereof or the like where caprylyl glycol is typically the most preferred.
When present in the leave-on composition, preservatives are added preferably in an amount 0.001 to 5 wt%, more preferably 0.01 to 3 wt% and most preferably 0.02 to 2 wt%, even most preferably 0.25 to 1.5%.
Preferably, the leave-on composition comprises a range of other optional ingredients that include antioxidants, binders, buffering agents, colorants, astringents, fragrance, opacifying agents, conditioners, exfoliating agents, pH adjusters, skin sensates, skin soothing agents, and skin healing agents.
The present invention relates to the method as described in detail herein above viz. the step of washing the surface with the wash-off composition followed by rinsing followed by applying a leave-on composition. It is preferrable to dry the skin after the rinsing step by dabbing the surface with a towel to leave the surface substantially dry to touch. The step of applying the leave-on composition after the rinsing off step may be carried out anywhere from a minute to an hour after the rinsing step. Preferably the step of applying the leave-on composition is from one minute to 30 minutes, more preferably one minute to 10 minutes, further more preferably from one minute to five minutes after the rinsing step. Preferably, the method is non-therapeutic or cosmetic in nature.
The invention also relates to a method of providing an SPF of 10, at least 20, preferably at least 30, more preferably at least 50, to the topical surface of the body. Preferably, the method is non- therapeutic or cosmetic in nature. The invention also relates to a method of providing an LIVAPF of 4 to skin, of at least 8, preferably atleast 12, more preferably at least 16 to the topical surface of the body. Preferably, the method is non-therapeutic or cosmetic in nature.
According to another aspect of the present invention, there is provided a kit comprising a hand held container comprising a pump capable of generating a foam, said container comprising a wash-off composition comprising 0.1 to 10 wt% of a water-soluble UVA sunscreen; 0.1 to 10 wt% of a water-soluble UVB sunscreen; 3 to 80 wt%, preferably 6 to 80 wt% a mild surfactant selected from one or more of an anionic, zwitterionic or non-ionic surfactant; and a cosmetically acceptable carrier; a leave-on composition comprising a sunscreen and a cosmetically acceptable vehicle; and instructions for use. Preferably, the use is non-therapeutic or cosmetic in nature.
The invention will now be demonstrated with the help of the following non-limiting examples.
Examples
Wash off Compositions 1-2: The following skin cleansing compositions were prepared as shown in Table - 1 below:
Leave-on Compositions: 3-5: The following leave-on compositions were prepared as shown in Table - 2 below:
For wash-off composition the protocol used was as follows: A pre-wet vitro skin was applied with diluted wash-off product of Composition 1 or 2. The vitro skin was rinsed off immediately post product application and kept for drying in dark. After the drying step, vitro skin was exposed to UV light and transmittance scan was recorded. This scan gives the transmittance as a function of wavelength (290 - 400 nm) for a given sample. For a single vitro skin sample four different spots were scanned. The same was repeated for 2 vitro skin samples. The data reported is thus an average over 8 readings. The reference transmittance scan was obtained using blank vitro skin, with glycerine spread on it as control. The transmittance values were used to arrive at the SPF and UVA PF values using the software provided with the instrument.
For leave-on composition the protocol used was as follows: The vitro skin post washing with Composition 1 or 2 was applied with 2mg /cm2 of leave-on product (Composition 3 or 4 or 5) on the same side of the vitro skin where cleansing was performed to mimic the consumer scenario. The vitro skin applied was then allowed to dry in the dark for 20-30 minutes to simulate recommended drying time from in vivo ISO 24444 methods. After drying, vitro skin was exposed to UV light and transmittance scan was recorded. This scan gives the transmittance as a function of wavelength (290 - 400 nm) for a given sample. For a single vitro skin sample four different spots were scanned. The same was repeated for 2 vitro skin samples. The data reported is thus an average over 8 readings. The reference transmittance scan was obtained using blank vitro skin, with glycerine spread on it as control. The transmittance values were used to arrive at the SPF and UVA PF values using the software provided with the instrument.
Example - 1 : The SPF and UVAPF of the substrate was measured after washing it with wash- off composition 1
Example - 2: The SPF and UVAPF of the substrate was measured after washing it with wash- off composition 2
Example - 3: The SPF and UVAPF of the substrate was measured after applying leave -on composition 3.
Example - 4: The SPF and LIVAPF of the substrate was measured after applying leave -on composition 4.
Example - 5: The SPF and LIVAPF of the substrate was measured after applying leave -on composition 5.
Example- 6: The SPF and LIVAPF of the substrate was measured after washing substrate with composition 1 followed by applying leave -on composition 3.
Example- 7: The SPF and LIVAPF of the substrate was measured after washing substrate with composition 1 followed by applying leave -on composition 4.
Example- 8: The SPF and LIVAPF of the substrate was measured after washing substrate with composition 1 followed by applying leave -on composition 5.
Example- 9: The SPF and LIVAPF of the substrate was measured after washing substrate with composition 2 followed by applying leave -on composition 3.
Example- 10: The SPF and LIVAPF of the substrate was measured after washing substrate with composition 2 followed by applying leave -on composition 4.
Example- 11 : The SPF and LIVAPF of the substrate was measured after washing substrate with composition 2 followed by applying leave -on composition 5.
The SPF and the UVA PF of the various Examples as listed above were measured and the data is summarised in Table -3 below:
The data in the table -3 above indicates that the method as per the invention (Examples 6-11) provides for synergistic improvement in SPF and LIVAPF over the individual steps of the method (Examples 1 to 5).
Claims
1. A method of providing high SPF to a topical surface of a body comprising the steps of
(a) washing the surface with a wash-off composition generated as a foam from a container comprising a pump, said wash-off composition comprising
(i) 0.1 to 10 wt% of a water-soluble UVA sunscreen;
(ii) 0.1 to 10 wt% of a water-soluble UVB sunscreen;
(iii) 3 to 80 wt%, preferably 6 to 80 wt% of a mild surfactant selected from one or more of an anionic, zwitterionic and non-ionic surfactant; and
(iv) a cosmetically acceptable carrier; preferably diluted with water followed by
(b) rinsing said surface with water; followed by
(c) applying a leave-on composition comprising a sunscreen and a cosmetically acceptable vehicle, on said surface.
2. A method as claimed in claim 1 wherein said anionic surfactant is selected from one or more of an isethionate, glycinate, cocoate, olefin sulphonate, sulphoacetate and sulphosuccinate surfactant.
3. A method as claimed in claim 1 wherein said zwitterionic surfactant is selected from one or more of a sultaine, betaine and amphoacetate surfactant.
4. A method as claimed in claim 1 wherein said non-ionic surfactant is selected from one or more of a polysorbate, sorbitan, polyethylene glycol and glucoside surfactant.
5. A method as claimed in any one of the preceding claims wherein the solubility in water of said water-soluble UVA sunscreen and said water-soluble UVB sunscreen is higher than 10 g/l at 25 °C.
6. A method as claimed in any one of the preceding claims wherein the water soluble UVB sunscreen is selected from phenyl benzimidazole sulphonic acid or benzylidene camphor sulfonic acid or mixtures thereof.
A method as claimed in any one of the preceding claims wherein said water soluble UVA sunscreen is selected from disodium phenyl dibenzimidazole tetra sulfonate, terephthalylidene dicamphor sulfonic acid or mixtures thereof. A method as claimed in any one of the preceding claims wherein the sunscreen in the leave-on composition is an organic UVA sunscreen, an organic UVB sunscreen, an inorganic sunblock or mixtures thereof preferably a combination of an organic UVB sunscreen and an organic UVA sunscreen. A method as claimed in claim 8 wherein said organic UVA sunscreen is butyl methoxydibenzoylmethane or diethylamino hydroxybenzoyl hexyl benzoate; said organic UVB sunscreen is ethylhexyl methoxycinnamate, Octocrylene, phenyl benzimidazole sulphonic acid, or ethyl hexyl salicylate; and said inorganic sunblock is zinc oxide or titanium dioxide. A method as claimed in any one of the preceding claims wherein said cosmetically acceptable vehicle of the leave-on composition is in the form of a cream, stick, lotion, gel or spray. A method as claimed in any one of the preceding claims wherein the step of applying the leave-on composition is carried out one minute to an hour after the step of rinsing said surface with water. A method as claimed in any one of the preceding claims for obtaining an SPF of at least 10. A kit comprising
(a) a hand held container comprising a pump capable of generating a foam, said container comprising a wash-off composition comprising 0.1 to 10 wt% of a water-soluble UVA sunscreen; 0.1 to 10 wt% of a water-soluble UVB sunscreen; 3 to 80 wt%, preferably 6 to 80 wt% a mild surfactant selected from one or more of an anionic, zwitterionic or non-ionic surfactant; and a cosmetically acceptable carrier;
(b) a leave-on composition comprising a sunscreen and a cosmetically acceptable vehicle; and
(c) Instructions for use.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP22202811 | 2022-10-20 | ||
EP22202811.0 | 2022-10-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024083721A1 true WO2024083721A1 (en) | 2024-04-25 |
Family
ID=83903255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2023/078633 WO2024083721A1 (en) | 2022-10-20 | 2023-10-16 | A method of providing high spf to a topical surface of a body |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024083721A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4585597A (en) | 1982-06-15 | 1986-04-29 | L'oreal | 3-benzylidene-camphors, process for their preparation and their use in protection against UV rays |
EP1261688A2 (en) | 2000-03-10 | 2002-12-04 | Unilever Plc | Personal wash sunscreen compositions which deposit and lather well |
US7025952B1 (en) * | 2005-01-31 | 2006-04-11 | Aquea Scientific Corporation | Methods of preparation and use of bodywashes containing additives |
WO2006083843A1 (en) * | 2005-01-31 | 2006-08-10 | Aquea Scientific Corporation | Additives for bodywashes |
US9655866B2 (en) | 2012-11-29 | 2017-05-23 | Conopco, Inc. | Mild antibacterial cleansing compositions |
WO2021245018A1 (en) * | 2020-06-02 | 2021-12-09 | Unilever Ip Holdings B.V. | A high spf skin cleansing composition |
-
2023
- 2023-10-16 WO PCT/EP2023/078633 patent/WO2024083721A1/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4585597A (en) | 1982-06-15 | 1986-04-29 | L'oreal | 3-benzylidene-camphors, process for their preparation and their use in protection against UV rays |
EP1261688A2 (en) | 2000-03-10 | 2002-12-04 | Unilever Plc | Personal wash sunscreen compositions which deposit and lather well |
US7025952B1 (en) * | 2005-01-31 | 2006-04-11 | Aquea Scientific Corporation | Methods of preparation and use of bodywashes containing additives |
WO2006083843A1 (en) * | 2005-01-31 | 2006-08-10 | Aquea Scientific Corporation | Additives for bodywashes |
US9655866B2 (en) | 2012-11-29 | 2017-05-23 | Conopco, Inc. | Mild antibacterial cleansing compositions |
WO2021245018A1 (en) * | 2020-06-02 | 2021-12-09 | Unilever Ip Holdings B.V. | A high spf skin cleansing composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2015147797A (en) | Polyurethanes as rheological modifying means for cosmetic preparations | |
CA2660527A1 (en) | Photostable cosmetic compositions | |
EP3073989A1 (en) | Novel emulsifying composition with cationic nature | |
CA3104962C (en) | An antimicrobial combination composition comprising glycerol derivatives and bicyclic compounds | |
EP3073988A1 (en) | Composition of alkyl polyglucosides and fatty esters of cationic amino acids | |
WO2024083721A1 (en) | A method of providing high spf to a topical surface of a body | |
EP1557161A1 (en) | Method for cleansing sensitive skin using an alkanolamine | |
EP2938320B1 (en) | A sunscreen composition comprising fatty acid and non-ionic linear polymer | |
EP3717607B1 (en) | Cleansing compositions and use thereof | |
US11883516B2 (en) | High SPF skin cleansing composition | |
US20230181440A1 (en) | A high uv protection cleansing composition | |
EP4346751A1 (en) | A method of providing high spf to a topical surface of a body | |
KR20210003865A (en) | Topical use of one or more umbels and plant seed oils for a soothing effect on reactive skin | |
CN113365600B (en) | Preservative systems and compositions containing them | |
US11419803B2 (en) | Skin darkening composition | |
US20040117921A1 (en) | Cosmetic composition, especially for dark hair | |
US20230270653A1 (en) | Use of trehalose for inhibiting ailment inducing microorganisms | |
WO2023030963A1 (en) | A photoprotective personal care composition | |
FR3029104A1 (en) | USE OF ESTERS OF ALPHA, OMEGA DIOLS AND N-ACYL DERIVATIVES OF AMINO ACIDS AS A BROWNING AND / OR TANNING AGENT OF HUMAN SKIN | |
GB2622125A (en) | Topical composition for nanobubble cosmetic | |
WO2023088725A1 (en) | A personal cleansing composition | |
WO2020249216A1 (en) | A cooling preparation | |
FR3029410A1 (en) | USE OF 1,3-BUTANEDIOL ESTERS AND N-ACYL DERIVATIVES OF AMINO ACIDS AS A BROWNING AND / OR TANNING AGENT OF HUMAN SKIN | |
FR3027515A1 (en) | USE OF ESTERS OF PHENYLALANINE AND POLYOLS AS A LIGHTENING AGENT FOR THE SKIN OF THE HUMAN BODY |